Autosomal Recessive Nonsyndromic Hearing Loss 102

Mendelian MONDO:0014428 Pathograph 10 Show in embeddings browser Autosomal Recessive Nonsyndromic Hearing Loss

DFNB102 is isolated, profound, congenital sensorineural hearing loss caused by biallelic loss of EPS8, the epidermal growth factor receptor pathway substrate 8. It was defined in two siblings of consanguineous Algerian parents who carried a homozygous nonsense allele, p.Gln30*, found by exome sequencing after the common DFNB genes had been excluded. It is very rare: by 2023 only five pathogenic EPS8 variants had been described, in Algerian, Chinese and Iranian families among others, and one of those required copy-number analysis to resolve - an apparently homozygous splice variant turned out to be a splice allele in trans with a 65.9 kb intragenic deletion. **The disease alleles remove the part of the protein that does the work.** EPS8's barbed-end capping activity resides in its conserved carboxy-terminal effector domain, and structural work separates the two activities within it: bundling through a compact four-helix bundle contacting three actin subunits along the filament, capping through an amphipathic helix that inserts into the hydrophobic pocket at the barbed end and blocks monomer addition. Point mutations can dissociate the two. The DFNB102 alleles are truncating or deleting, so both are lost together - which is why this entry has no capping-versus-bundling distinction to make at the level of patients, only at the level of the protein. **EPS8 sets stereocilia length.** Each stereocilium in a hair bundle is a bundle of tightly packed, uniformly polarized actin filaments whose growth is regulated at the barbed ends, at the stereociliary tip. EPS8 has actin binding, bundling and barbed-end capping activities, localizes predominantly to the stereocilia tip, and is required for normal elongation. Eps8 knockout mice are profoundly deaf and have abnormally short hair bundle stereocilia. The link from allele to phenotype is therefore a structural one: the sensory antenna is built too short to detect physiological sound pressures. **There is a second, non-structural arm, and it is confined to inner hair cells.** In Eps8-null mice, inner and outer hair cells both have short stereocilia, but only inner hair cells additionally fail to acquire their mature basolateral ion channel complement, so they do not complete the transition into functional sensory receptors. That is a maturation defect rather than a bundle defect, and it is the reason this entry carries two parallel downstream arms from one molecular lesion rather than one. **Why it is non-syndromic has a mechanistic answer.** EPS8 is expressed in vestibular hair cells too, and those cells also have significantly shorter stereocilia in the null mouse - yet the mice show no vestibular deficit. The difference is that vestibular hair cells keep a normal pattern of basolateral voltage-dependent channels and can still respond to a stimulus, where inner hair cells lose the ability to synchronize their responses. So the restriction of the phenotype to hearing is not "EPS8 is only needed in the cochlea"; it is that the same bundle abnormality is functionally tolerated in one organ and not the other. **EPS8 is one node of a tip complex, not a solo actor.** It works with MYO15A, whirlin and GPSM2-Gai in a tip-complex density that has been reconstituted in vitro and behaves as a phase-separated condensate promoting actin bundling; MYO15A delivers EPS8 to the tip as cargo, and EPS8 in turn is required to localize BAIAP2L2 there. Several of those partners are themselves deafness genes, which is the argument for reading DFNB102 as one lesion in a shared machine.

Ask OpenScientist

Ask a research question about Autosomal Recessive Nonsyndromic Hearing Loss 102. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
6
Pathophys.
2
Phenotypes
1
Gaps
10
Pathograph
1
Genes
2
Variants
3
Medical Actions
1
Models
13
References
1
Deep Research
👪

Inheritance

1
Autosomal recessive HP:0000007
Biallelic EPS8 loss of function. In the founding family the nonsense allele was homozygous in both affected siblings, present heterozygously in both unaffected parents and in one unaffected sibling, and absent from two other unaffected siblings - the full segregation pattern for a recessive allele.
Autosomal recessive inheritance
Show evidence (1 reference)
PMID:24741995 SUPPORT Human Clinical
"The mutation was also present, in the heterozygous state, in one clinically unaffected sibling and in both unaffected parents, and was absent from the other two unaffected siblings."
The segregation data. Heterozygous carriers are unaffected, which is what establishes the recessive mode rather than merely being consistent with it.
?

Discussions and Knowledge Gaps

1
Do humans with biallelic EPS8 loss have subclinical vestibular dysfunction, as the mouse hair-cell data predict they should, and has anyone looked?
HUMAN MODEL MISMATCH eps8_vestibular_silence_in_humans
The mouse gives an unusually specific prediction here, and it is a prediction about a negative. Eps8-null vestibular hair cells have significantly shorter stereocilia but keep a normal basolateral channel pattern and normal voltage responses, and the animals show no vestibular deficit. The authors' own explanation is that vestibular deficits are sometimes centrally compensated, which is a statement about detectability rather than about absence. The human side is silent rather than concordant. The founding family is described as having isolated deafness, which is the basis for calling the entity non-syndromic, but the paper reports no vestibular testing - and a shortened vestibular hair bundle that is centrally compensated is exactly what a clinical history would miss. So "non-syndromic" here rests on the absence of a reported complaint in two individuals, against a model that predicts a measurable abnormality with no complaint. This is a HUMAN_MODEL_MISMATCH rather than a KNOWLEDGE_GAP because the evidence exists and is good; what is open is whether the mouse's compensated-vestibular state translates, and the answer would change what a family is told about balance and about late vestibular decompensation.
Proposed experiments
Vestibular function testing in EPS8 biallelic carriers
eps8_vestibular_function_testing
Video head impulse testing and vestibular evoked myogenic potentials in reported EPS8 biallelic individuals, against age-matched deaf controls with a gene unrelated to the hair bundle. Central compensation preserves clinical balance but not the reflex measurements, so the measurements are where the mouse prediction is testable.
Readouts
Vestibulo-ocular reflex gain on video head impulse testing
Direction: DECREASED
Interpretation: Reduced gain with no balance complaint would reproduce the mouse's compensated state in humans; normal gain would mean the human vestibular system tolerates EPS8 loss better than the mouse's does.
Supporting outcome
  • Reduced vestibulo-ocular reflex gain or absent vestibular evoked myogenic potentials in EPS8 biallelic individuals who report no balance symptoms.
Refuting outcome
  • Vestibular reflex measurements indistinguishable from deaf controls, indicating the human vestibular system is unaffected rather than compensated.
⚙

Pathophysiology

6
EPS8 Loss of Function
Mechanism confidence: Established
A biallelic nonsense allele near the start of the coding sequence removes EPS8. EPS8 is an F-actin capping and bundling protein present in the hair bundle, so the loss is of a regulator of actin dynamics at the site where stereocilia grow.
EPS8 hgnc:3420 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves EPS8 (hgnc:3420). hgnc:3420 is a gene from the HUGO Gene Nomenclature Committee.
barbed-end actin filament capping GO:0051016 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased barbed-end actin filament capping (GO:0051016). GO:0051016 is a biological process from the Gene Ontology. ↓ DECREASED actin filament bundle assembly GO:0051017 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased actin filament bundle assembly (GO:0051017). GO:0051017 is a biological process from the Gene Ontology. ↓ DECREASED
stereocilium tip GO:0032426 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves stereocilium tip (GO:0032426). GO:0032426 is a cellular component from the Gene Ontology.
Show evidence (2 references)
PMID:24741995 SUPPORT Human Clinical
"EPS8 is an F-actin capping and bundling protein."
What the lost protein does, stated in the human genetics paper rather than inferred from the mouse work.
PMID:21526224 SUPPORT Model Organism
"We show that Eps8, a protein with actin binding, bundling, and barbed-end capping activities in other systems, is a novel component of the hair bundle."
Places EPS8 in the hair bundle and names the three activities it brings there.
Loss of the C-Terminal Effector Domain
Mechanism confidence: Established
The structural specification of what the disease alleles take away. EPS8's barbed-end capping activity resides in its conserved carboxy-terminal effector domain, and within that domain capping and bundling are separable: capping by an amphipathic helix inserting into the hydrophobic pocket at the filament barbed end, bundling by a compact four-helix bundle contacting the filament. A nonsense codon at residue 30 of an 822-residue protein removes both. This node exists because the separability matters for interpretation rather than for these patients: a hypothetical missense allele sparing one activity would be a different disease state, and none has been reported.
barbed-end actin filament capping GO:0051016 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased barbed-end actin filament capping (GO:0051016). GO:0051016 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (2 references)
PMID:15558031 SUPPORT In Vitro
"proteins of another family, the Eps8 family, also show barbed-end capping activity, which resides in their conserved carboxy-terminal effector domain"
Locates the capping activity in the C-terminal effector domain, which is the region a truncating DFNB102 allele removes.
PMID:20532239 SUPPORT In Vitro
"The capping activity is mainly mediated by a amphipathic helix that binds within the hydrophobic pocket at the barbed ends of actin blocking further addition of actin monomers."
The structural mechanism of capping, and the basis for treating capping and bundling as separable activities of one domain. Note the source's own typo, "a amphipathic", is preserved because a snippet quotes rather than corrects.
Failure of Stereocilia Elongation
Mechanism confidence: Established
Without EPS8 at the barbed ends, the actin core does not reach its normal length. Both inner and outer hair cells in the Eps8-null mouse have abnormally short stereocilia. This is a failure to build rather than a degeneration: the elongation step itself does not complete.
cochlear inner and outer hair cell CL:0000202 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cochlear inner and outer hair cell, annotated with auditory hair cell (CL:0000202). CL:0000202 is a cell type from the Cell Ontology.
auditory receptor cell stereocilium organization GO:0060088 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased auditory receptor cell stereocilium organization (GO:0060088). GO:0060088 is a biological process from the Gene Ontology. ↓ DECREASED
stereocilium GO:0032420 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves stereocilium (GO:0032420). GO:0032420 is a cellular component from the Gene Ontology.
cochlea UBERON:0001844 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cochlea (UBERON:0001844). UBERON:0001844 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (2 references)
PMID:21526224 SUPPORT Model Organism
"Eps8 is localized predominantly at the tip of the stereocilia and is essential for their normal elongation and function."
Localization and requirement together, which is what makes the tip the place the lesion acts.
PMID:27132230 SUPPORT Model Organism
"While both inner and outer hair cells from Eps8 knockout (KO) mice showed abnormally short stereocilia, inner hair cells (IHCs) also failed to acquire mature-type ion channels."
Records that the bundle defect is shared by both cochlear hair cell types while the maturation defect is not, which is the dissociation this entry models as two arms.
Arrested Functional Maturation of Inner Hair Cells
Mechanism confidence: Established
Inner hair cells do not complete the developmental transition into mature sensory receptors. They fail to acquire the mature-type basolateral ion channels, and they lose the ability to synchronize their responses to a sinusoidal stimulus. This is separable from the stereocilia defect: vestibular hair cells in the same animal have short stereocilia and a normal basolateral channel pattern.
cochlear inner hair cell CL:0000589 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cochlear inner hair cell (CL:0000589). CL:0000589 is a cell type from the Cell Ontology.
inner ear receptor cell differentiation GO:0060113 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased inner ear receptor cell differentiation (GO:0060113). GO:0060113 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (1 reference)
PMID:27132230 SUPPORT Model Organism
"We have also found that while vestibular hair cells from Eps8 KO mice show normal voltage responses to injected sinusoidal currents, which were used to mimic the mechanoelectrical transducer current, IHCs lose their ability to synchronize their responses to the stimulus."
The functional measurement behind this node, and the direct vestibular comparison in the same experiment.
Compromised Detection of Physiological Sound Pressures
Mechanism confidence: Established
The convergence node. A hair bundle that is too short, served by inner hair cells that have not matured, cannot transduce sound at normal pressures. The founding human genetics paper states the inference in exactly these terms.
sensory perception of sound GO:0007605 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased sensory perception of sound (GO:0007605). GO:0007605 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (1 reference)
PMID:24741995 SUPPORT PRIMARY RESULT Human Clinical
"This new DFNB form is likely to arise from abnormal hair bundles resulting in compromised detection of physiological sound pressures."
The authors' own statement of the mechanism they propose for the disease they defined. Note the hedge - "is likely to arise from" - is theirs and is deliberately preserved rather than smoothed out; this is an inference from the mouse phenotype, not a measurement in the patients.
EPS8 as a Node of the Stereocilia Tip Complex
Mechanism confidence: Established
EPS8 does not act alone at the tip. It is delivered there as cargo of the motor protein MYO15A, it is in turn required for BAIAP2L2 to localize at the tips of the transducing stereocilia, and reconstituted Whirlin-MYO15-EPS8 assemblies form phase-separated condensates that promote actin bundling. Several partners in that complex are themselves deafness genes, so DFNB102 is best read as removing one component of a shared machine rather than as an isolated gene defect.
actin filament bundle assembly GO:0051017 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves actin filament bundle assembly (GO:0051017). GO:0051017 is a biological process from the Gene Ontology.
stereocilium tip GO:0032426 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves stereocilium tip (GO:0032426). GO:0032426 is a cellular component from the Gene Ontology.
Show evidence (4 references)
PMID:33626355 SUPPORT In Vitro
"we discover that the specific multivalent interactions among the Whirlin-myosin 15 (Myo15)-Eps8 complex lead to the formation of the TCD-like condensates through liquid-liquid phase separation."
The reconstitution showing EPS8 is one of three components of a condensate, not a free protein at the tip.
PMID:33626355 SUPPORT In Vitro
"The reconstituted TCD-like condensates effectively promote actin bundling."
Connects the complex to the actin activity that the disease lesion removes.
PMID:21236676 SUPPORT Model Organism
"MyoXVa, whirlin, and Eps8 are integral components of the stereocilia tip complex"
Names the three components of the tip complex and places EPS8 among them, which is the basis for reading DFNB102 as one lesion in a shared machine.
+ 1 more reference
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Autosomal Recessive Nonsyndromic Hearing Loss 102 Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

2
Ear 1
Profound congenital sensorineural hearing impairment Profound sensorineural hearing impairment HP:0011476 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Profound sensorineural hearing impairment (HP:0011476). HP:0011476 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24741995 SUPPORT Human Clinical
"We report the study of two siblings born to consanguineous Algerian parents and affected by isolated, profound congenital deafness."
The phenotype as observed in the only reported family: isolated, profound, and congenital.
Nervous System 1
Delayed speech and language development HP:0000750 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Delayed speech and language development (HP:0000750). HP:0000750 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:41895171 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical
"post-implant spoken language outcomes remain highly heterogeneous, ranging from robust speech recognition and age-appropriate language to minimal benefits in sound detection with limited speech perception and language delays."
Establishes language delay as a real and variable outcome in this population. A narrative review, hence REVIEW_SYNTHESIS, and about congenital severe-to-profound SNHL rather than about EPS8, hence INDIRECT.
🧬

Genetic Associations

1
EPS8
Gene: EPS8 hgnc:3420 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is EPS8 (hgnc:3420). hgnc:3420 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Show evidence (2 references)
PMID:24741995 SUPPORT Human Clinical
"A biallelic nonsense mutation, c.88C > T (p.Gln30*), was identified in EPS8 that encodes epidermal growth factor receptor pathway substrate 8, a 822 amino-acid protein involved in actin dynamics."
The gene-disease assertion and the founding allele, from the exome study that established DFNB102.
PMID:36635257 SUPPORT Human Clinical
"we report the fifth pathogenic variant in the EPS8 gene in an Iranian patient with DFNB102"
Sizes the allelic series - five pathogenic variants reported by 2023 - which is the basis for the rarity statement in the description and for not calling this a single-family disease.
🔬

Variants

2
EPS8 c.88C>T p.Gln30* Pathogenic
single nucleotide variant
The founding DFNB102 allele, homozygous in two Algerian siblings. A nonsense codon at residue 30 of an 822 residue protein, so essentially the whole coding sequence is lost. It was absent from 120 Algerian normal-hearing controls and from the Exome Variant Server.
Show evidence (2 references)
PMID:24741995 SUPPORT Human Clinical
"This mutation predicts a truncated inactive protein or no protein at all."
The authors' reading of the allele's consequence, which is what licenses treating the mouse null as the relevant model.
PMID:24741995 SUPPORT Human Clinical
"It was not found in 120 Algerian normal hearing control individuals or in the Exome Variant Server database."
Population absence, the frequency argument for pathogenicity in a consanguineous family study.
EPS8 c.1435-2A>T in trans with a 65.9 kb intragenic deletion Pathogenic
deletion
A compound-heterozygous genotype in a non-consanguineous Chinese infant that trio exome sequencing first read as homozygous for the splice variant. Copy-number analysis found a 65.9 kb intragenic deletion covering intron 14 on the maternal allele, which explained the apparent homozygosity. Recorded because of what it implies for diagnosis rather than for mechanism: a DFNB102 genotype can be missed, or mis-assigned as homozygous, by sequencing alone.
Show evidence (1 reference)
PMID:34637946 SUPPORT Human Clinical
"The deletion is covering intron 14 that could account for the apparent homozygosity of the patient."
The copy-number finding and its diagnostic consequence, in the report that made it.
💊

Medical Actions

3
Cochlear implantation
Action: cochlear device implantationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is cochlear device implantation, annotated with Surgical Procedure (NCIT:C15329), qualified as medical device cochlear implant. NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Platform: Device
Prelingual profound sensorineural hearing loss from a hair-bundle lesion is the indication cochlear implantation exists for: the sensory transduction step fails while the auditory nerve is intact, so direct electrical stimulation bypasses the defect. No publication cited here reports implantation outcomes in an EPS8 patient - the reported cohorts are genetics papers - so the evidence below is the general indication for congenital severe-to-profound sensorineural hearing loss rather than an EPS8-specific result. It is what these children receive.
Show evidence (1 reference)
PMID:41895171 SUPPORT REVIEW SYNTHESIS Human Clinical
"Pediatric cochlear implantation is the standard of care for infants and young children with congenital bilateral severe-to-profound sensorineural hearing loss who receive limited benefits from optimally fitted hearing aids."
The indication, verbatim, including the hearing-aid trial that defines it. A narrative review rather than a trial, and about the indication rather than about DFNB102, so it supports the treatment being appropriate here without claiming an EPS8-specific result.
Hearing aid trial
Action: hearing aid amplificationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is hearing aid amplification, annotated with Supportive Care (NCIT:C15747), qualified as medical device hearing aid. NCIT:C15747 is a clinical intervention from the NCI Thesaurus. Ontology label: Supportive Care NCIT:C15747
Platform: Device
Optimally fitted amplification is attempted first and is typically insufficient at this severity - which is not a failure of the trial but its purpose, since limited benefit from optimally fitted hearing aids is part of the definition of the cochlear implant indication. Recorded for that reason rather than as an expected treatment.
Show evidence (1 reference)
PMID:41895171 SUPPORT REVIEW SYNTHESIS Human Clinical
"Pediatric cochlear implantation is the standard of care for infants and young children with congenital bilateral severe-to-profound sensorineural hearing loss who receive limited benefits from optimally fitted hearing aids."
The trailing clause is what makes the hearing-aid trial part of the implant indication rather than an alternative to it. Quoted as the whole sentence rather than the clause alone so the snippet is a proposition on its own.
Auditory-verbal and speech-language therapy
Action: post-implant auditory-verbal and speech-language therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is post-implant auditory-verbal and speech-language therapy, annotated with Rehabilitation (NCIT:C15315). NCIT:C15315 is a clinical intervention from the NCI Thesaurus. Ontology label: Rehabilitation NCIT:C15315
Platform: Behavioral / lifestyle
Post-implant habilitation. The review that supplies this entry's implantation evidence exists because outcomes after implantation vary widely, and it organizes the predictors into intrinsic and extrinsic factors with clinically actionable strategies - which is to say the device is the beginning of the intervention rather than the end of it.
Show evidence (1 reference)
PMID:41895171 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical
"This narrative review integrates findings from the literature by organizing predictors of post-implant language development into intrinsic and extrinsic factors and highlighting clinically actionable strategies to optimize interventions."
Establishes that post-implant intervention is a managed variable rather than a fixed outcome. It does not name auditory-verbal therapy specifically, so the claim that this named therapy belongs here follows by an inference step - which is what INDIRECT encodes, and the reason it is set on this item.
🔬

Diagnosis

1
Copy-number analysis alongside sequencing
The distinctive diagnostic point for this gene, and the reason it belongs in `diagnosis:` rather than only in `variants:`. A trio exome first read one patient as HOMOZYGOUS for an EPS8 splice variant; copy-number analysis then found a 65.9 kb intragenic deletion covering the same intron on the maternal allele. An intragenic deletion in trans with a sequence variant masquerades as homozygosity, so a sequencing-only workflow does not merely miss the second allele - it reports the wrong genotype, with the wrong recurrence risk for the parents.
Show evidence (1 reference)
PMID:34637946 SUPPORT Human Clinical
"The deletion is covering intron 14 that could account for the apparent homozygosity of the patient."
The copy-number finding and the explanation of the apparent homozygosity it resolved.
📊

Prevalence

1
Worldwide
Cases In Literature Ultra Rare
No prevalence estimate exists. Five pathogenic EPS8 variants had been described by 2023, in a handful of families. Recorded as a qualitative tier against CASES_IN_LITERATURE rather than as an invented rate, which CLAUDE.md permits precisely because that measure presupposes no numeric estimate.
Show evidence (1 reference)
PMID:36635257 SUPPORT Human Clinical
"Thus far, only four pathogenic variations in EPS8 have been described. In this study, we report the fifth pathogenic variant in the EPS8 gene in an Iranian patient with DFNB102."
The count of reported pathogenic variants at the time of the fifth report, which is as close to a denominator as this disease has.
🐁

Animal Models

1
Eps8 knockout mouse
The model that carries this entry's mechanism. Eps8-null mice are profoundly deaf with abnormally short stereocilia in both cochlear hair cell types, and inner hair cells additionally fail to mature. The same animal also has a phenotype with no human counterpart, which is worth recording rather than filtering out: reduced body weight, partial resistance to diet-induced obesity, improved metabolic status and increased lifespan, correlated with about 25 percent shorter intestinal microvilli. Microvilli are actin-cored protrusions like stereocilia, so this is the same molecular lesion in a different actin-based structure - and it is absent from the human disease, where EPS8 loss gives isolated deafness.
Species
Mouse
Genotype
Eps8 homozygous knockout
Publication
Show evidence (1 reference)
PMID:20209148 SUPPORT Model Organism
"a 25% reduction in intestinal microvilli length"
The extra-auditory phenotype of the same null mouse, recorded so that the model's scope is visible. Humans with biallelic EPS8 loss are reported as having isolated deafness, so this is a divergence rather than an unexamined human phenotype - though see review_notes, since nobody has looked for it either.
{ }

Source YAML

click to show
name: Autosomal Recessive Nonsyndromic Hearing Loss 102
category: Mendelian
creation_date: "2026-09-22T13:20:00Z"
synonyms:
- DFNB102
- deafness, autosomal recessive 102
- autosomal recessive nonsyndromic deafness 102
- EPS8-related nonsyndromic hearing loss
description: >-
  DFNB102 is isolated, profound, congenital sensorineural hearing loss caused by
  biallelic loss of EPS8, the epidermal growth factor receptor pathway substrate 8.
  It was defined in two siblings of consanguineous Algerian parents who carried a
  homozygous nonsense allele, p.Gln30*, found by exome sequencing after the common
  DFNB genes had been excluded. It is very rare: by 2023 only five pathogenic EPS8
  variants had been described, in Algerian, Chinese and Iranian families among others,
  and one of those required copy-number analysis to resolve - an apparently homozygous
  splice variant turned out to be a splice allele in trans with a 65.9 kb intragenic
  deletion.

  **The disease alleles remove the part of the protein that does the work.** EPS8's
  barbed-end capping activity resides in its conserved carboxy-terminal effector domain,
  and structural work separates the two activities within it: bundling through a compact
  four-helix bundle contacting three actin subunits along the filament, capping through
  an amphipathic helix that inserts into the hydrophobic pocket at the barbed end and
  blocks monomer addition. Point mutations can dissociate the two. The DFNB102 alleles
  are truncating or deleting, so both are lost together - which is why this entry has no
  capping-versus-bundling distinction to make at the level of patients, only at the level
  of the protein.

  **EPS8 sets stereocilia length.** Each stereocilium in a hair bundle is a bundle of
  tightly packed, uniformly polarized actin filaments whose growth is regulated at the
  barbed ends, at the stereociliary tip. EPS8 has actin binding, bundling and
  barbed-end capping activities, localizes predominantly to the stereocilia tip, and
  is required for normal elongation. Eps8 knockout mice are profoundly deaf and have
  abnormally short hair bundle stereocilia. The link from allele to phenotype is
  therefore a structural one: the sensory antenna is built too short to detect
  physiological sound pressures.

  **There is a second, non-structural arm, and it is confined to inner hair cells.**
  In Eps8-null mice, inner and outer hair cells both have short stereocilia, but only
  inner hair cells additionally fail to acquire their mature basolateral ion channel
  complement, so they do not complete the transition into functional sensory
  receptors. That is a maturation defect rather than a bundle defect, and it is the
  reason this entry carries two parallel downstream arms from one molecular lesion
  rather than one.

  **Why it is non-syndromic has a mechanistic answer.** EPS8 is expressed in
  vestibular hair cells too, and those cells also have significantly shorter
  stereocilia in the null mouse - yet the mice show no vestibular deficit. The
  difference is that vestibular hair cells keep a normal pattern of basolateral
  voltage-dependent channels and can still respond to a stimulus, where inner hair
  cells lose the ability to synchronize their responses. So the restriction of the
  phenotype to hearing is not "EPS8 is only needed in the cochlea"; it is that the
  same bundle abnormality is functionally tolerated in one organ and not the other.

  **EPS8 is one node of a tip complex, not a solo actor.** It works with MYO15A,
  whirlin and GPSM2-Gai in a tip-complex density that has been reconstituted in vitro
  and behaves as a phase-separated condensate promoting actin bundling; MYO15A
  delivers EPS8 to the tip as cargo, and EPS8 in turn is required to localize
  BAIAP2L2 there. Several of those partners are themselves deafness genes, which is
  the argument for reading DFNB102 as one lesion in a shared machine.
disease_term:
  preferred_term: autosomal recessive nonsyndromic hearing loss 102
  term:
    id: MONDO:0014428
    label: autosomal recessive nonsyndromic hearing loss 102
parents:
- Autosomal Recessive Nonsyndromic Hearing Loss
references:
- reference: PMID:24741995
  title: "EPS8, encoding an actin-binding protein of cochlear hair cell stereocilia, is a new causal gene for autosomal recessive profound deafness."
- reference: PMID:21526224
  title: "Eps8 regulates hair bundle length and functional maturation of mammalian auditory hair cells."
- reference: PMID:27132230
  title: "Distinct roles of Eps8 in the maturation of cochlear and vestibular hair cells."
- reference: PMID:33151556
  title: "Loss of Baiap2l2 destabilizes the transducing stereocilia of cochlear hair cells and leads to deafness."
- reference: PMID:33626355
  title: "Phase separation-mediated condensation of Whirlin-Myo15-Eps8 stereocilia tip complex."
- reference: PMID:15558031
  title: "Eps8 controls actin-based motility by capping the barbed ends of actin filaments."
- reference: PMID:20532239
  title: "Molecular basis for the dual function of Eps8 on actin dynamics: bundling and capping."
- reference: PMID:21236676
  title: "Regulation of stereocilia length by myosin XVa and whirlin depends on the actin-regulatory protein Eps8."
- reference: PMID:34637946
  title: "Apparent homozygosity for a novel splicing variant in EPS8 causes congenital profound hearing loss."
- reference: PMID:36635257
  title: "EPS8 variant causes deafness, autosomal recessive 102 (DFNB102) and literature review."
- reference: PMID:20209148
  title: "Loss of the actin remodeler Eps8 causes intestinal defects and improved metabolic status in mice."
- reference: PMID:41895171
  title: "Language development after pediatric cochlear implantation: Why outcomes vary and how to optimize clinical management."
- reference: PMID:20301607
  title: "Genetic Hearing Loss Overview."
  tags:
  - GeneReviews
inheritance:
- name: Autosomal recessive
  description: >-
    Biallelic EPS8 loss of function. In the founding family the nonsense allele was
    homozygous in both affected siblings, present heterozygously in both unaffected
    parents and in one unaffected sibling, and absent from two other unaffected
    siblings - the full segregation pattern for a recessive allele.
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  evidence:
  - reference: PMID:24741995
    reference_title: "EPS8, encoding an actin-binding protein of cochlear hair cell stereocilia, is a new causal gene for autosomal recessive profound deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The mutation was also present, in the heterozygous state, in one clinically unaffected sibling and in both unaffected parents, and was absent from the other two unaffected siblings."
    explanation: >-
      The segregation data. Heterozygous carriers are unaffected, which is what
      establishes the recessive mode rather than merely being consistent with it.
genetic:
- name: EPS8
  notes: >-
    EPS8 encodes an 822 amino-acid actin regulator with F-actin capping and bundling
    activity. In hair cells it is a component of the hair bundle, concentrated at the
    stereocilia tip, and is delivered there by the myosin motor MYO15A.
  relationship_type: CAUSATIVE
  gene_term:
    preferred_term: EPS8
    term:
      id: hgnc:3420
      label: EPS8
  evidence:
  - reference: PMID:24741995
    reference_title: "EPS8, encoding an actin-binding protein of cochlear hair cell stereocilia, is a new causal gene for autosomal recessive profound deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A biallelic nonsense mutation, c.88C > T (p.Gln30*), was identified in EPS8 that encodes epidermal growth factor receptor pathway substrate 8, a 822 amino-acid protein involved in actin dynamics."
    explanation: >-
      The gene-disease assertion and the founding allele, from the exome study that
      established DFNB102.
  - reference: PMID:36635257
    reference_title: "EPS8 variant causes deafness, autosomal recessive 102 (DFNB102) and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we report the fifth pathogenic variant in the EPS8 gene in an Iranian patient with DFNB102"
    explanation: >-
      Sizes the allelic series - five pathogenic variants reported by 2023 - which is
      the basis for the rarity statement in the description and for not calling this a
      single-family disease.
variants:
- name: EPS8 c.88C>T p.Gln30*
  description: >-
    The founding DFNB102 allele, homozygous in two Algerian siblings. A nonsense codon
    at residue 30 of an 822 residue protein, so essentially the whole coding sequence
    is lost. It was absent from 120 Algerian normal-hearing controls and from the Exome
    Variant Server.
  variant_type: single nucleotide variant
  clinical_significance: PATHOGENIC
  evidence:
  - reference: PMID:24741995
    reference_title: "EPS8, encoding an actin-binding protein of cochlear hair cell stereocilia, is a new causal gene for autosomal recessive profound deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This mutation predicts a truncated inactive protein or no protein at all."
    explanation: >-
      The authors' reading of the allele's consequence, which is what licenses treating
      the mouse null as the relevant model.
  - reference: PMID:24741995
    reference_title: "EPS8, encoding an actin-binding protein of cochlear hair cell stereocilia, is a new causal gene for autosomal recessive profound deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It was not found in 120 Algerian normal hearing control individuals or in the Exome Variant Server database."
    explanation: >-
      Population absence, the frequency argument for pathogenicity in a consanguineous
      family study.
- name: EPS8 c.1435-2A>T in trans with a 65.9 kb intragenic deletion
  description: >-
    A compound-heterozygous genotype in a non-consanguineous Chinese infant that trio
    exome sequencing first read as homozygous for the splice variant. Copy-number
    analysis found a 65.9 kb intragenic deletion covering intron 14 on the maternal
    allele, which explained the apparent homozygosity.

    Recorded because of what it implies for diagnosis rather than for mechanism: a
    DFNB102 genotype can be missed, or mis-assigned as homozygous, by sequencing alone.
  variant_type: deletion
  clinical_significance: PATHOGENIC
  evidence:
  - reference: PMID:34637946
    reference_title: "Apparent homozygosity for a novel splicing variant in EPS8 causes congenital profound hearing loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The deletion is covering intron 14 that could account for the apparent homozygosity of the patient."
    explanation: >-
      The copy-number finding and its diagnostic consequence, in the report that made it.
pathophysiology:
- name: EPS8 Loss of Function
  description: >-
    A biallelic nonsense allele near the start of the coding sequence removes EPS8.
    EPS8 is an F-actin capping and bundling protein present in the hair bundle, so the
    loss is of a regulator of actin dynamics at the site where stereocilia grow.
  biological_scale: MOLECULAR
  mechanism_confidence: ESTABLISHED
  genes:
  - preferred_term: EPS8
    term:
      id: hgnc:3420
      label: EPS8
  cellular_components:
  - preferred_term: stereocilium tip
    term:
      id: GO:0032426
      label: stereocilium tip
  biological_processes:
  - preferred_term: barbed-end actin filament capping
    modifier: DECREASED
    term:
      id: GO:0051016
      label: barbed-end actin filament capping
  - preferred_term: actin filament bundle assembly
    modifier: DECREASED
    term:
      id: GO:0051017
      label: actin filament bundle assembly
  downstream:
  - target: Loss of the C-Terminal Effector Domain
    causal_link_type: DIRECT
  - target: Failure of Stereocilia Elongation
    causal_link_type: DIRECT
  - target: Arrested Functional Maturation of Inner Hair Cells
    causal_link_type: DIRECT
    description: >-
      A second, separable consequence. Eps8-null inner hair cells fail to acquire the
      mature basolateral ion channel complement, which is not a consequence of their
      stereocilia being short.
    evidence:
    - reference: PMID:21526224
      reference_title: "Eps8 regulates hair bundle length and functional maturation of mammalian auditory hair cells."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Moreover, we have found that Eps8 knockout mice are profoundly deaf and that IHCs, but not OHCs, fail to mature into fully functional sensory receptors."
      explanation: >-
        Establishes the maturation arm and that it is cell-type restricted, which is
        why it hangs off the molecular node rather than off the bundle node.
  evidence:
  - reference: PMID:24741995
    reference_title: "EPS8, encoding an actin-binding protein of cochlear hair cell stereocilia, is a new causal gene for autosomal recessive profound deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "EPS8 is an F-actin capping and bundling protein."
    explanation: >-
      What the lost protein does, stated in the human genetics paper rather than
      inferred from the mouse work.
  - reference: PMID:21526224
    reference_title: "Eps8 regulates hair bundle length and functional maturation of mammalian auditory hair cells."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We show that Eps8, a protein with actin binding, bundling, and barbed-end capping activities in other systems, is a novel component of the hair bundle."
    explanation: >-
      Places EPS8 in the hair bundle and names the three activities it brings there.
- name: Loss of the C-Terminal Effector Domain
  description: >-
    The structural specification of what the disease alleles take away. EPS8's
    barbed-end capping activity resides in its conserved carboxy-terminal effector
    domain, and within that domain capping and bundling are separable: capping by an
    amphipathic helix inserting into the hydrophobic pocket at the filament barbed end,
    bundling by a compact four-helix bundle contacting the filament. A nonsense codon at
    residue 30 of an 822-residue protein removes both.

    This node exists because the separability matters for interpretation rather than for
    these patients: a hypothetical missense allele sparing one activity would be a
    different disease state, and none has been reported.
  biological_scale: MOLECULAR
  mechanism_confidence: ESTABLISHED
  biological_processes:
  - preferred_term: barbed-end actin filament capping
    modifier: DECREASED
    term:
      id: GO:0051016
      label: barbed-end actin filament capping
  downstream:
  - target: Failure of Stereocilia Elongation
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:15558031
    reference_title: "Eps8 controls actin-based motility by capping the barbed ends of actin filaments."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "proteins of another family, the Eps8 family, also show barbed-end capping activity, which resides in their conserved carboxy-terminal effector domain"
    explanation: >-
      Locates the capping activity in the C-terminal effector domain, which is the
      region a truncating DFNB102 allele removes.
  - reference: PMID:20532239
    reference_title: "Molecular basis for the dual function of Eps8 on actin dynamics: bundling and capping."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The capping activity is mainly mediated by a amphipathic helix that binds within the hydrophobic pocket at the barbed ends of actin blocking further addition of actin monomers."
    explanation: >-
      The structural mechanism of capping, and the basis for treating capping and
      bundling as separable activities of one domain. Note the source's own typo, "a
      amphipathic", is preserved because a snippet quotes rather than corrects.
- name: Failure of Stereocilia Elongation
  description: >-
    Without EPS8 at the barbed ends, the actin core does not reach its normal length.
    Both inner and outer hair cells in the Eps8-null mouse have abnormally short
    stereocilia. This is a failure to build rather than a degeneration: the elongation
    step itself does not complete.
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  cell_types:
  - preferred_term: cochlear inner and outer hair cell
    term:
      id: CL:0000202
      label: auditory hair cell
  cellular_components:
  - preferred_term: stereocilium
    term:
      id: GO:0032420
      label: stereocilium
  biological_processes:
  - preferred_term: auditory receptor cell stereocilium organization
    modifier: DECREASED
    term:
      id: GO:0060088
      label: auditory receptor cell stereocilium organization
  locations:
  - preferred_term: cochlea
    term:
      id: UBERON:0001844
      label: cochlea
  downstream:
  - target: Compromised Detection of Physiological Sound Pressures
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:21526224
    reference_title: "Eps8 regulates hair bundle length and functional maturation of mammalian auditory hair cells."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Eps8 is localized predominantly at the tip of the stereocilia and is essential for their normal elongation and function."
    explanation: >-
      Localization and requirement together, which is what makes the tip the place the
      lesion acts.
  - reference: PMID:27132230
    reference_title: "Distinct roles of Eps8 in the maturation of cochlear and vestibular hair cells."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "While both inner and outer hair cells from Eps8 knockout (KO) mice showed abnormally short stereocilia, inner hair cells (IHCs) also failed to acquire mature-type ion channels."
    explanation: >-
      Records that the bundle defect is shared by both cochlear hair cell types while
      the maturation defect is not, which is the dissociation this entry models as two
      arms.
- name: Arrested Functional Maturation of Inner Hair Cells
  description: >-
    Inner hair cells do not complete the developmental transition into mature sensory
    receptors. They fail to acquire the mature-type basolateral ion channels, and they
    lose the ability to synchronize their responses to a sinusoidal stimulus. This is
    separable from the stereocilia defect: vestibular hair cells in the same animal
    have short stereocilia and a normal basolateral channel pattern.
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  cell_types:
  - preferred_term: cochlear inner hair cell
    term:
      id: CL:0000589
      label: cochlear inner hair cell
  biological_processes:
  - preferred_term: inner ear receptor cell differentiation
    modifier: DECREASED
    term:
      id: GO:0060113
      label: inner ear receptor cell differentiation
  downstream:
  - target: Compromised Detection of Physiological Sound Pressures
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:27132230
    reference_title: "Distinct roles of Eps8 in the maturation of cochlear and vestibular hair cells."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We have also found that while vestibular hair cells from Eps8 KO mice show normal voltage responses to injected sinusoidal currents, which were used to mimic the mechanoelectrical transducer current, IHCs lose their ability to synchronize their responses to the stimulus."
    explanation: >-
      The functional measurement behind this node, and the direct vestibular comparison
      in the same experiment.
- name: Compromised Detection of Physiological Sound Pressures
  description: >-
    The convergence node. A hair bundle that is too short, served by inner hair cells
    that have not matured, cannot transduce sound at normal pressures. The founding
    human genetics paper states the inference in exactly these terms.
  biological_scale: ORGANISM
  mechanism_confidence: ESTABLISHED
  biological_processes:
  - preferred_term: sensory perception of sound
    modifier: DECREASED
    term:
      id: GO:0007605
      label: sensory perception of sound
  downstream:
  - target: Profound congenital sensorineural hearing impairment
    causal_link_type: DIRECT
  - target: Delayed speech and language development
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:24741995
    reference_title: "EPS8, encoding an actin-binding protein of cochlear hair cell stereocilia, is a new causal gene for autosomal recessive profound deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: "This new DFNB form is likely to arise from abnormal hair bundles resulting in compromised detection of physiological sound pressures."
    explanation: >-
      The authors' own statement of the mechanism they propose for the disease they
      defined. Note the hedge - "is likely to arise from" - is theirs and is
      deliberately preserved rather than smoothed out; this is an inference from the
      mouse phenotype, not a measurement in the patients.
- name: EPS8 as a Node of the Stereocilia Tip Complex
  description: >-
    EPS8 does not act alone at the tip. It is delivered there as cargo of the motor
    protein MYO15A, it is in turn required for BAIAP2L2 to localize at the tips of the
    transducing stereocilia, and reconstituted Whirlin-MYO15-EPS8 assemblies form
    phase-separated condensates that promote actin bundling. Several partners in that
    complex are themselves deafness genes, so DFNB102 is best read as removing one
    component of a shared machine rather than as an isolated gene defect.
  biological_scale: MOLECULAR
  mechanism_confidence: ESTABLISHED
  cellular_components:
  - preferred_term: stereocilium tip
    term:
      id: GO:0032426
      label: stereocilium tip
  biological_processes:
  - preferred_term: actin filament bundle assembly
    term:
      id: GO:0051017
      label: actin filament bundle assembly
  downstream:
  - target: Failure of Stereocilia Elongation
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Drawn as an indirect link because the complex's role is the context in which the
      elongation failure happens, and the reconstitution work was not done on the
      DFNB102 allele.
  evidence:
  - reference: PMID:33626355
    reference_title: "Phase separation-mediated condensation of Whirlin-Myo15-Eps8 stereocilia tip complex."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "we discover that the specific multivalent interactions among the Whirlin-myosin 15 (Myo15)-Eps8 complex lead to the formation of the TCD-like condensates through liquid-liquid phase separation."
    explanation: >-
      The reconstitution showing EPS8 is one of three components of a condensate, not a
      free protein at the tip.
  - reference: PMID:33626355
    reference_title: "Phase separation-mediated condensation of Whirlin-Myo15-Eps8 stereocilia tip complex."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The reconstituted TCD-like condensates effectively promote actin bundling."
    explanation: >-
      Connects the complex to the actin activity that the disease lesion removes.
  - reference: PMID:21236676
    reference_title: "Regulation of stereocilia length by myosin XVa and whirlin depends on the actin-regulatory protein Eps8."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "MyoXVa, whirlin, and Eps8 are integral components of the stereocilia tip complex"
    explanation: >-
      Names the three components of the tip complex and places EPS8 among them, which is
      the basis for reading DFNB102 as one lesion in a shared machine.
  - reference: PMID:33151556
    reference_title: "Loss of Baiap2l2 destabilizes the transducing stereocilia of cochlear hair cells and leads to deafness."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "BAIAP2L2 localization to stereocilia tips is dependent on the motor protein MYO15A and its cargo EPS8"
    explanation: >-
      Places EPS8 downstream of MYO15A and upstream of BAIAP2L2 in the delivery
      hierarchy, which is what makes the complex an ordered assembly rather than a list.
phenotypes:
- category: Auditory
  name: Profound congenital sensorineural hearing impairment
  description: >-
    Isolated, profound congenital deafness in both affected siblings of the founding
    family. Profound is the reported severity, and congenital is the reported onset.
  phenotype_term:
    preferred_term: Profound sensorineural hearing impairment
    term:
      id: HP:0011476
      label: Profound sensorineural hearing impairment
  evidence:
  - reference: PMID:24741995
    reference_title: "EPS8, encoding an actin-binding protein of cochlear hair cell stereocilia, is a new causal gene for autosomal recessive profound deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We report the study of two siblings born to consanguineous Algerian parents and affected by isolated, profound congenital deafness."
    explanation: >-
      The phenotype as observed in the only reported family: isolated, profound, and
      congenital.
- category: Neurologic
  name: Delayed speech and language development
  description: >-
    Language delay is the functional consequence of prelingual profound deafness, and
    it remains the principal outcome being managed after cochlear implantation.
    Post-implant spoken language outcomes are highly heterogeneous, from
    age-appropriate language to persistent delay.

    No source reports language outcomes in an EPS8 patient specifically. The evidence
    below is general to congenital severe-to-profound sensorineural hearing loss and is
    graded INDIRECT for that reason, which is the honest position - an earlier draft
    left the node entirely uncited on the stricter and wrong standard that only a
    DFNB102-specific source would do.
  phenotype_term:
    preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  evidence:
  - reference: PMID:41895171
    reference_title: "Language development after pediatric cochlear implantation: Why outcomes vary and how to optimize clinical management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    directness: INDIRECT
    snippet: "post-implant spoken language outcomes remain highly heterogeneous, ranging from robust speech recognition and age-appropriate language to minimal benefits in sound detection with limited speech perception and language delays."
    explanation: >-
      Establishes language delay as a real and variable outcome in this population. A
      narrative review, hence REVIEW_SYNTHESIS, and about congenital severe-to-profound
      SNHL rather than about EPS8, hence INDIRECT.
treatments:
- name: Cochlear implantation
  description: >-
    Prelingual profound sensorineural hearing loss from a hair-bundle lesion is the
    indication cochlear implantation exists for: the sensory transduction step fails
    while the auditory nerve is intact, so direct electrical stimulation bypasses the
    defect. No publication cited here reports implantation outcomes in an EPS8 patient
    - the reported cohorts are genetics papers - so the evidence below is the general
    indication for congenital severe-to-profound sensorineural hearing loss rather than
    an EPS8-specific result. It is what these children receive.
  treatment_term:
    preferred_term: cochlear device implantation
    term:
      id: NCIT:C15329
      label: Surgical Procedure
    qualifiers:
    - predicate:
        preferred_term: medical device
        term:
          id: NCIT:C16830
          label: Medical Device
      value:
        preferred_term: cochlear implant
        term:
          id: NCIT:C157820
          label: Cochlear Implant
  therapeutic_modality: DEVICE
  evidence:
  - reference: PMID:41895171
    reference_title: "Language development after pediatric cochlear implantation: Why outcomes vary and how to optimize clinical management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "Pediatric cochlear implantation is the standard of care for infants and young children with congenital bilateral severe-to-profound sensorineural hearing loss who receive limited benefits from optimally fitted hearing aids."
    explanation: >-
      The indication, verbatim, including the hearing-aid trial that defines it. A
      narrative review rather than a trial, and about the indication rather than about
      DFNB102, so it supports the treatment being appropriate here without claiming an
      EPS8-specific result.
- name: Hearing aid trial
  description: >-
    Optimally fitted amplification is attempted first and is typically insufficient at
    this severity - which is not a failure of the trial but its purpose, since limited
    benefit from optimally fitted hearing aids is part of the definition of the cochlear
    implant indication. Recorded for that reason rather than as an expected treatment.
  treatment_term:
    preferred_term: hearing aid amplification
    term:
      id: NCIT:C15747
      label: Supportive Care
    qualifiers:
    - predicate:
        preferred_term: medical device
        term:
          id: NCIT:C16830
          label: Medical Device
      value:
        preferred_term: hearing aid
        term:
          id: NCIT:C183182
          label: Hearing Aid
  therapeutic_modality: DEVICE
  evidence:
  - reference: PMID:41895171
    reference_title: "Language development after pediatric cochlear implantation: Why outcomes vary and how to optimize clinical management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "Pediatric cochlear implantation is the standard of care for infants and young children with congenital bilateral severe-to-profound sensorineural hearing loss who receive limited benefits from optimally fitted hearing aids."
    explanation: >-
      The trailing clause is what makes the hearing-aid trial part of the implant
      indication rather than an alternative to it. Quoted as the whole sentence rather
      than the clause alone so the snippet is a proposition on its own.
- name: Auditory-verbal and speech-language therapy
  description: >-
    Post-implant habilitation. The review that supplies this entry's implantation
    evidence exists because outcomes after implantation vary widely, and it organizes
    the predictors into intrinsic and extrinsic factors with clinically actionable
    strategies - which is to say the device is the beginning of the intervention rather
    than the end of it.
  treatment_term:
    preferred_term: post-implant auditory-verbal and speech-language therapy
    term:
      id: NCIT:C15315
      label: Rehabilitation
  therapeutic_modality: BEHAVIORAL
  evidence:
  - reference: PMID:41895171
    reference_title: "Language development after pediatric cochlear implantation: Why outcomes vary and how to optimize clinical management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    directness: INDIRECT
    snippet: "This narrative review integrates findings from the literature by organizing predictors of post-implant language development into intrinsic and extrinsic factors and highlighting clinically actionable strategies to optimize interventions."
    explanation: >-
      Establishes that post-implant intervention is a managed variable rather than a
      fixed outcome. It does not name auditory-verbal therapy specifically, so the claim
      that this named therapy belongs here follows by an inference step - which is what
      INDIRECT encodes, and the reason it is set on this item.
animal_models:
- name: Eps8 knockout mouse
  species: Mouse
  genotype: Eps8 homozygous knockout
  publication: PMID:21526224
  description: >-
    The model that carries this entry's mechanism. Eps8-null mice are profoundly deaf
    with abnormally short stereocilia in both cochlear hair cell types, and inner hair
    cells additionally fail to mature.

    The same animal also has a phenotype with no human counterpart, which is worth
    recording rather than filtering out: reduced body weight, partial resistance to
    diet-induced obesity, improved metabolic status and increased lifespan, correlated
    with about 25 percent shorter intestinal microvilli. Microvilli are actin-cored
    protrusions like stereocilia, so this is the same molecular lesion in a different
    actin-based structure - and it is absent from the human disease, where EPS8 loss
    gives isolated deafness.
  modeled_mechanisms:
  - target: Failure of Stereocilia Elongation
    relationship: RECAPITULATES
    fidelity: HIGH
    model_scale: CELLULAR
    description: >-
      Short stereocilia in both inner and outer hair cells, with profound deafness.
    limitations: >-
      The mouse is a constitutive null and the human founding allele is a nonsense codon
      at residue 30 predicted to give truncated inactive protein or none, so the
      genotypes correspond unusually well here. What does not correspond is the
      extra-auditory phenotype: the mouse has an intestinal and metabolic syndrome that
      humans with biallelic EPS8 loss do not report.
    divergences:
    - divergence_type: SPECIES_MISMATCH
      materiality: IMMATERIAL
      description: >-
        The null mouse has a 25 percent reduction in intestinal microvilli length with
        an associated metabolic phenotype; human EPS8 disease is isolated deafness.
        Marked IMMATERIAL because it does not bear on this link's claim about
        stereocilia - but it is recorded because a reader should know the model carries
        a phenotype the disease does not, and because microvilli and stereocilia are
        the same kind of structure, which makes the human silence informative rather
        than merely reassuring.
    readouts:
    - name: Stereocilia length in cochlear hair cells
      target: Failure of Stereocilia Elongation
      direction: DECREASED
      interpretation: >-
        Abnormally short stereocilia in both hair cell types, the structural lesion this
        node names.
      evidence:
      - reference: PMID:27132230
        reference_title: "Distinct roles of Eps8 in the maturation of cochlear and vestibular hair cells."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "While both inner and outer hair cells from Eps8 knockout (KO) mice showed abnormally short stereocilia, inner hair cells (IHCs) also failed to acquire mature-type ion channels."
        explanation: >-
          The measured stereocilia phenotype, with the inner-hair-cell-specific
          maturation defect alongside it.
  - target: Arrested Functional Maturation of Inner Hair Cells
    relationship: RECAPITULATES
    fidelity: HIGH
    model_scale: CELLULAR
    description: >-
      Inner hair cells fail to mature into fully functional sensory receptors, while
      outer hair cells are comparatively spared.
    readouts:
    - name: Acquisition of mature-type basolateral ion channels in inner hair cells
      target: Arrested Functional Maturation of Inner Hair Cells
      direction: ABOLISHED
      interpretation: >-
        Inner hair cells do not acquire the mature channel complement.
      evidence:
      - reference: PMID:21526224
        reference_title: "Eps8 regulates hair bundle length and functional maturation of mammalian auditory hair cells."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Moreover, we have found that Eps8 knockout mice are profoundly deaf and that IHCs, but not OHCs, fail to mature into fully functional sensory receptors."
        explanation: >-
          The maturation failure and its restriction to inner hair cells.
  evidence:
  - reference: PMID:20209148
    reference_title: "Loss of the actin remodeler Eps8 causes intestinal defects and improved metabolic status in mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "a 25% reduction in intestinal microvilli length"
    explanation: >-
      The extra-auditory phenotype of the same null mouse, recorded so that the model's
      scope is visible. Humans with biallelic EPS8 loss are reported as having isolated
      deafness, so this is a divergence rather than an unexamined human phenotype -
      though see review_notes, since nobody has looked for it either.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    No prevalence estimate exists. Five pathogenic EPS8 variants had been described by
    2023, in a handful of families. Recorded as a qualitative tier against
    CASES_IN_LITERATURE rather than as an invented rate, which CLAUDE.md permits
    precisely because that measure presupposes no numeric estimate.
  evidence:
  - reference: PMID:36635257
    reference_title: "EPS8 variant causes deafness, autosomal recessive 102 (DFNB102) and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Thus far, only four pathogenic variations in EPS8 have been described. In this study, we report the fifth pathogenic variant in the EPS8 gene in an Iranian patient with DFNB102."
    explanation: >-
      The count of reported pathogenic variants at the time of the fifth report, which
      is as close to a denominator as this disease has.
diagnosis:
- name: Copy-number analysis alongside sequencing
  description: >-
    The distinctive diagnostic point for this gene, and the reason it belongs in
    `diagnosis:` rather than only in `variants:`. A trio exome first read one patient as
    HOMOZYGOUS for an EPS8 splice variant; copy-number analysis then found a 65.9 kb
    intragenic deletion covering the same intron on the maternal allele. An intragenic
    deletion in trans with a sequence variant masquerades as homozygosity, so a
    sequencing-only workflow does not merely miss the second allele - it reports the
    wrong genotype, with the wrong recurrence risk for the parents.
  evidence:
  - reference: PMID:34637946
    reference_title: "Apparent homozygosity for a novel splicing variant in EPS8 causes congenital profound hearing loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The deletion is covering intron 14 that could account for the apparent homozygosity of the patient."
    explanation: >-
      The copy-number finding and the explanation of the apparent homozygosity it
      resolved.
discussions:
- discussion_id: eps8_vestibular_silence_in_humans
  kind: HUMAN_MODEL_MISMATCH
  prompt: >-
    Do humans with biallelic EPS8 loss have subclinical vestibular dysfunction, as the
    mouse hair-cell data predict they should, and has anyone looked?
  attaches_to:
  - pathophysiology#Arrested Functional Maturation of Inner Hair Cells
  rationale: >-
    The mouse gives an unusually specific prediction here, and it is a prediction about
    a negative. Eps8-null vestibular hair cells have significantly shorter stereocilia
    but keep a normal basolateral channel pattern and normal voltage responses, and
    the animals show no vestibular deficit. The authors' own explanation is that
    vestibular deficits are sometimes centrally compensated, which is a statement about
    detectability rather than about absence.

    The human side is silent rather than concordant. The founding family is described
    as having isolated deafness, which is the basis for calling the entity
    non-syndromic, but the paper reports no vestibular testing - and a shortened
    vestibular hair bundle that is centrally compensated is exactly what a clinical
    history would miss. So "non-syndromic" here rests on the absence of a reported
    complaint in two individuals, against a model that predicts a measurable
    abnormality with no complaint.

    This is a HUMAN_MODEL_MISMATCH rather than a KNOWLEDGE_GAP because the evidence
    exists and is good; what is open is whether the mouse's compensated-vestibular
    state translates, and the answer would change what a family is told about balance
    and about late vestibular decompensation.
  proposed_experiments:
  - experiment_id: eps8_vestibular_function_testing
    name: Vestibular function testing in EPS8 biallelic carriers
    description: >-
      Video head impulse testing and vestibular evoked myogenic potentials in reported
      EPS8 biallelic individuals, against age-matched deaf controls with a gene
      unrelated to the hair bundle. Central compensation preserves clinical balance but
      not the reflex measurements, so the measurements are where the mouse prediction
      is testable.
    readouts:
    - name: Vestibulo-ocular reflex gain on video head impulse testing
      target: pathophysiology#Arrested Functional Maturation of Inner Hair Cells
      direction: DECREASED
      interpretation: >-
        Reduced gain with no balance complaint would reproduce the mouse's compensated
        state in humans; normal gain would mean the human vestibular system tolerates
        EPS8 loss better than the mouse's does.
    would_support:
    - pathophysiology#Arrested Functional Maturation of Inner Hair Cells
    supporting_outcome:
    - >-
      Reduced vestibulo-ocular reflex gain or absent vestibular evoked myogenic
      potentials in EPS8 biallelic individuals who report no balance symptoms.
    refuting_outcome:
    - >-
      Vestibular reflex measurements indistinguishable from deaf controls, indicating
      the human vestibular system is unaffected rather than compensated.
notes: >-
  Ontology gaps, and where specificity was deliberately not manufactured.

  "Failure of Stereocilia Elongation" binds CL:0000202 auditory hair cell rather than
  the narrower CL:0000589 cochlear inner hair cell or CL:0000601 cochlear outer hair
  cell, because the cited result is explicitly about both types - "both inner and outer
  hair cells from Eps8 knockout (KO) mice showed abnormally short stereocilia". Binding
  either narrow term would assert a cell-type restriction the source denies. The
  maturation node does bind CL:0000589, because there the source restricts it.

  A negative-existence note in an earlier draft of this entry was WRONG and is recorded
  here rather than quietly deleted, because the mistake is the one CLAUDE.md warns about
  by name. The draft said no GO term names "barbed-end actin filament capping", on the
  strength of grepping cache/go/terms.csv and getting no rows. The term exists:
  GO:0051016 barbed-end actin filament capping, confirmed with
  `runoak -i ols:go info GO:0051016` and `runoak -i ols:go search "l~barbed-end actin
  filament capping"`, which also returns the three regulation terms beneath it. The
  cache was empty because nothing in kb/ had bound it yet, and an empty cache is silence,
  not a negative answer - the cache-first contract read backwards. GO:0051016 is now
  bound on the molecular node and on the effector-domain node, where it is the exact
  process the disease alleles remove. The error was caught by the committed
  OpenScientist deep-research report, which named the CURIE.

  The GeneReviews baseline for this disorder is PMID:20301607 Genetic Hearing Loss
  Overview; it is tagged in `references:` and carries no evidence item, because nothing
  in it is quoted. There is no EPS8-specific or DFNB102-specific GeneReviews chapter -
  verified offline against cache/bookshelf/genereviews.csv.
review_notes: >-
  The mouse's extra-auditory phenotype is recorded as a divergence marked IMMATERIAL, and
  the wording there is careful on purpose. Eps8-null mice have 25 percent shorter
  intestinal microvilli with a metabolic phenotype; humans with biallelic EPS8 loss are
  described as having isolated deafness. But "isolated" in those reports means no
  reported syndromic feature in a handful of patients, not a negative metabolic workup -
  nobody has looked. Microvilli and stereocilia are the same kind of actin-cored
  structure, so this is a place where the human silence may be absence of evidence.

  Evidence base. Five pathogenic EPS8 variants had been described by 2023, across
  Algerian, Chinese and Iranian families. The founding family is two siblings with a
  homozygous nonsense allele; the pathograph is carried by mouse and in vitro work
  rather than by the patients. An earlier draft of this entry said "one human family"
  and was corrected after the deep-research report surfaced the later reports - the
  original framing came from reading the founding paper and stopping there.

  Every pathophysiology node below the molecular one is evidenced from mouse or in
  vitro work, and each is graded MODEL_ORGANISM or IN_VITRO accordingly. The only
  HUMAN_CLINICAL evidence in the pathograph is the allele itself and the authors'
  closing inference about sound pressures, which is graded PRIMARY_RESULT but is an
  inference and is flagged as one in its explanation. A reviewer should read the
  mechanism as mouse-derived.

  Two records previously carried no evidence and no term on the reasoning that only a
  DFNB102-specific source would do. Review was right that this is stricter than dismech
  uses: general-mechanism evidence is routine, cochlear implantation for prelingual
  profound SNHL is not a DFNB102-specific claim, and the supporting reference was
  already committed in this PR and uncited. Both now cite PMID:41895171 with
  quote_role REVIEW_SYNTHESIS, the phenotype at directness INDIRECT, and the
  Delayed speech and language development node is bound to HP:0000750, which was an
  exact-name match sitting in cache/hp/terms.csv the whole time. The term and the
  evidence were separate decisions and I had conflated them.

  One CURIE I wrote from memory was wrong, and is recorded because it landed in the
  slot CLAUDE.md names as the blind spot. The hearing-aid qualifier was first written
  as NCIT:C50108 "Hearing Aid"; NCIT:C50108 is Plug Device. `just validate` and
  `just validate-terms` both pass on a fabricated qualifier value, because
  Qualifier.value is a plain Descriptor with no dynamic-enum binding. It was caught by
  running `runoak -i ols:ncit info` before committing, and the correct term is
  NCIT:C183182 Hearing Aid, which is already in cache/ncit/terms.csv.

  Two further defects came out of the push that answered round 1, and both were in
  prose rather than in data. The Cochlear implantation description still said the
  record carried no evidence block after an evidence block had been added directly
  beneath it, which review caught. And a line of the language-delay description ended
  in "post-" inside a folded scalar, which turned CI red: `check-folded-hyphens` takes
  no file argument, so the per-file loop I had been running could not see it. Both are
  fixed here. The shape they share is that neither is reachable from the file being
  edited alone.
📚

References & Deep Research

References

13
EPS8, encoding an actin-binding protein of cochlear hair cell stereocilia, is a new causal gene for autosomal recessive profound deafness.
No top-level findings curated for this source.
Eps8 regulates hair bundle length and functional maturation of mammalian auditory hair cells.
No top-level findings curated for this source.
Distinct roles of Eps8 in the maturation of cochlear and vestibular hair cells.
No top-level findings curated for this source.
Loss of Baiap2l2 destabilizes the transducing stereocilia of cochlear hair cells and leads to deafness.
No top-level findings curated for this source.
Phase separation-mediated condensation of Whirlin-Myo15-Eps8 stereocilia tip complex.
No top-level findings curated for this source.
Eps8 controls actin-based motility by capping the barbed ends of actin filaments.
No top-level findings curated for this source.
Molecular basis for the dual function of Eps8 on actin dynamics: bundling and capping.
No top-level findings curated for this source.
Regulation of stereocilia length by myosin XVa and whirlin depends on the actin-regulatory protein Eps8.
No top-level findings curated for this source.
Apparent homozygosity for a novel splicing variant in EPS8 causes congenital profound hearing loss.
No top-level findings curated for this source.
EPS8 variant causes deafness, autosomal recessive 102 (DFNB102) and literature review.
No top-level findings curated for this source.
Loss of the actin remodeler Eps8 causes intestinal defects and improved metabolic status in mice.
No top-level findings curated for this source.
Language development after pediatric cochlear implantation: Why outcomes vary and how to optimize clinical management.
No top-level findings curated for this source.
Genetic Hearing Loss Overview.
No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (3)

Record review notes

The mouse's extra-auditory phenotype is recorded as a divergence marked IMMATERIAL, and the wording there is careful on purpose. Eps8-null mice have 25 percent shorter intestinal microvilli with a metabolic phenotype; humans with biallelic EPS8 loss are described as having isolated deafness. But "isolated" in those reports means no reported syndromic feature in a handful of patients, not a negative metabolic workup - nobody has looked. Microvilli and stereocilia are the same kind of actin-cored structure, so this is a place where the human silence may be absence of evidence. Evidence base. Five pathogenic EPS8 variants had been described by 2023, across Algerian, Chinese and Iranian families. The founding family is two siblings with a homozygous nonsense allele; the pathograph is carried by mouse and in vitro work rather than by the patients. An earlier draft of this entry said "one human family" and was corrected after the deep-research report surfaced the later reports - the original framing came from reading the founding paper and stopping there. Every pathophysiology node below the molecular one is evidenced from mouse or in vitro work, and each is graded MODEL_ORGANISM or IN_VITRO accordingly. The only HUMAN_CLINICAL evidence in the pathograph is the allele itself and the authors' closing inference about sound pressures, which is graded PRIMARY_RESULT but is an inference and is flagged as one in its explanation. A reviewer should read the mechanism as mouse-derived. Two records previously carried no evidence and no term on the reasoning that only a DFNB102-specific source would do. Review was right that this is stricter than dismech uses: general-mechanism evidence is routine, cochlear implantation for prelingual profound SNHL is not a DFNB102-specific claim, and the supporting reference was already committed in this PR and uncited. Both now cite PMID:41895171 with quote_role REVIEW_SYNTHESIS, the phenotype at directness INDIRECT, and the Delayed speech and language development node is bound to HP:0000750, which was an exact-name match sitting in cache/hp/terms.csv the whole time. The term and the evidence were separate decisions and I had conflated them. One CURIE I wrote from memory was wrong, and is recorded because it landed in the slot CLAUDE.md names as the blind spot. The hearing-aid qualifier was first written as NCIT:C50108 "Hearing Aid"; NCIT:C50108 is Plug Device. `just validate` and `just validate-terms` both pass on a fabricated qualifier value, because Qualifier.value is a plain Descriptor with no dynamic-enum binding. It was caught by running `runoak -i ols:ncit info` before committing, and the correct term is NCIT:C183182 Hearing Aid, which is already in cache/ncit/terms.csv. Two further defects came out of the push that answered round 1, and both were in prose rather than in data. The Cochlear implantation description still said the record carried no evidence block after an evidence block had been added directly beneath it, which review caught. And a line of the language-delay description ended in "post-" inside a folded scalar, which turned CI red: `check-folded-hyphens` takes no file argument, so the per-file loop I had been running could not see it. Both are fixed here. The shape they share is that neither is reachable from the file being edited alone.

Record notes

Ontology gaps, and where specificity was deliberately not manufactured. "Failure of Stereocilia Elongation" binds CL:0000202 auditory hair cell rather than the narrower CL:0000589 cochlear inner hair cell or CL:0000601 cochlear outer hair cell, because the cited result is explicitly about both types - "both inner and outer hair cells from Eps8 knockout (KO) mice showed abnormally short stereocilia". Binding either narrow term would assert a cell-type restriction the source denies. The maturation node does bind CL:0000589, because there the source restricts it. A negative-existence note in an earlier draft of this entry was WRONG and is recorded here rather than quietly deleted, because the mistake is the one CLAUDE.md warns about by name. The draft said no GO term names "barbed-end actin filament capping", on the strength of grepping cache/go/terms.csv and getting no rows. The term exists: GO:0051016 barbed-end actin filament capping, confirmed with `runoak -i ols:go info GO:0051016` and `runoak -i ols:go search "l~barbed-end actin filament capping"`, which also returns the three regulation terms beneath it. The cache was empty because nothing in kb/ had bound it yet, and an empty cache is silence, not a negative answer - the cache-first contract read backwards. GO:0051016 is now bound on the molecular node and on the effector-domain node, where it is the exact process the disease alleles remove. The error was caught by the committed OpenScientist deep-research report, which named the CURIE. The GeneReviews baseline for this disorder is PMID:20301607 Genetic Hearing Loss Overview; it is tagged in `references:` and carries no evidence item, because nothing in it is quoted. There is no EPS8-specific or DFNB102-specific GeneReviews chapter - verified offline against cache/bookshelf/genereviews.csv.

Create: Autosomal Recessive Nonsyndromic Hearing Loss 102 (MONDO:0014428) · 2026-09-22T13:32:21Z · View source

De novo curation of DFNB102 / EPS8-related nonsyndromic hearing loss (MONDO:0014428), claimed in #12502. entry_type decision: DISEASE. A single-gene, single-MONDO-term leaf under hearing loss, autosomal recessive. Pathograph: five nodes. One molecular lesion (EPS8 loss of function) with two separable downstream arms - failure of stereocilia elongation, shared by inner and outer hair cells, and arrested functional maturation confined to inner hair cells - converging on compromised detection of physiological sound pressures. A fifth node records EPS8 as one component of the MYO15A/whirlin/GPSM2 stereocilia tip complex rather than as a solo actor. Cell-type binding note: the elongation node binds CL:0000202 auditory hair cell rather than the narrower inner or outer hair cell terms, because the cited result is explicitly about both. The maturation node binds CL:0000589 cochlear inner hair cell, because there the source restricts it. Recorded human-model mismatch: Eps8-null mice have shortened vestibular stereocilia with no vestibular deficit, which the authors attribute to central compensation. The founding human family is described as having isolated deafness, but no vestibular testing is reported - so 'non-syndromic' rests on the absence of a complaint in two individuals against a model that predicts a measurable abnormality with no complaint. Proposed experiment records the reflex measurements that would distinguish the readings. Evidence base is deliberately stated as thin: one human family, two siblings, one homozygous nonsense allele, with the mechanism carried by mouse and in vitro work. Every pathograph node below the molecular one is graded MODEL_ORGANISM or IN_VITRO. One phenotype (Delayed speech and language development) carries no evidence block, deliberately, because no cited source reports speech outcomes in an EPS8 patient. This is stated in the node description and in review_notes. Validation: just validate, just validate-terms, just count-verified-snippets (15/15). Deep research reconciliation. The committed OpenScientist report materially changed this entry and caught one error of mine. Corrected: an earlier draft's notes said no GO term names "barbed-end actin filament capping", on the strength of an empty cache/go/terms.csv grep. The term exists (GO:0051016), confirmed with runoak against ols:go. An empty cache is silence, not a negative answer. The false note is replaced by a note recording the mistake, and GO:0051016 is now bound where it belongs. Corrected: the draft said the entry rests on "one human family". Five pathogenic EPS8 variants had been described by 2023, across Algerian, Chinese and Iranian families. The original framing came from reading the founding paper and stopping. Added from the report, each verified against a freshly fetched cache: a C-terminal-effector-domain pathophysiology node with the structural separation of capping from bundling (PMID:15558031, PMID:20532239); the MYO15A/whirlin/EPS8 tip complex statement (PMID:21236676); the compound splice-plus-65.9 kb-deletion genotype that sequencing alone read as homozygous (PMID:34637946); an Eps8 knockout mouse model with the extra-auditory intestinal and metabolic phenotype recorded as a typed divergence (PMID:20209148); and cochlear implantation. Reference titles were twice written from descriptive text rather than copied from the cache frontmatter, and twice caught by the title check. They are now set programmatically from the references_cache title field. Review round 1 (PR #12512). Both IMPORTANT items and all four suggestions taken. HP:0000750 bound to the Delayed speech and language development phenotype. The node name was verbatim the HPO label and the term was already in cache/hp/terms.csv. My description explained why the node had no evidence and said nothing about why it had no term; those were separate decisions and I had conflated them. PMID:41895171 cited on both the cochlear implantation treatment and the language phenotype. It was committed in this PR and uncited - the shape of a decision made and reversed. The bar I had set, that only a DFNB102-specific source would do, is stricter than dismech uses: general-mechanism evidence is routine, and cochlear implantation for prelingual profound SNHL is not a gene-specific claim. Graded REVIEW_SYNTHESIS, and INDIRECT on the phenotype. Added: prevalence as CASES_IN_LITERATURE with an ULTRA_RARE tier; a diagnosis block covering the copy-number point, which for this gene is not a completeness note but a correctness one - sequencing alone reported the wrong genotype in a real patient; a hearing-aid trial row, recorded because limited benefit from optimally fitted amplification is part of the implant indication rather than an alternative to it; and post-implant auditory-verbal and speech-language therapy. Duplicate PMID:36635257 references entry removed. One CURIE I wrote from memory was wrong. The hearing-aid qualifier was first written as NCIT:C50108 "Hearing Aid"; that code is Plug Device. Both just validate and just validate-terms pass on it, because Qualifier.value is a plain Descriptor with no dynamic-enum binding - the blind spot CLAUDE.md documents. Caught by running runoak before committing. Corrected to NCIT:C183182, verified in cache/ncit/terms.csv, and recorded in the entry notes. HP:0008619 for bilaterality not added. The reviewer marked it optional and noted that carrying laterality as a qualifier is equally defensible; the existing HP:0011476 node's evidence quotes a two-sibling family and no cached source states a bilaterality frequency, so a second phenotype would add a claim without a source.

OpenScientist ▸
Autosomal Recessive Nonsyndromic Hearing Loss 102 (DFNB102): A Comprehensive Disease Report
openscientist-autonomous 16 citations 2026-09-22T13:49:51.437495

Autosomal Recessive Nonsyndromic Hearing Loss 102 (DFNB102): A Comprehensive Disease Report

Disease: Autosomal Recessive Nonsyndromic Hearing Loss 102 (DFNB102) MONDO ID: MONDO:0014428 · OMIM: 615974 · Causal gene: EPS8 (12p12.3) Report type: Aggregated disease-level synthesis of primary literature and ontology resources


Summary

Autosomal Recessive Nonsyndromic Hearing Loss 102 (DFNB102) is an ultrarare Mendelian sensorineural deafness caused by biallelic loss-of-function variants in EPS8, the gene encoding Epidermal Growth Factor Receptor Pathway Substrate 8, an 822-amino-acid F-actin capping and bundling protein. The disease was first defined in 2014, when whole-exome sequencing of a consanguineous Algerian family identified a homozygous nonsense variant, c.88C>T (p.Gln30), segregating with isolated profound congenital deafness (PMID: 24741995). DFNB102 is genetically and clinically homogeneous within its small case series: affected individuals present with prelingual/congenital, bilateral, symmetric, severe-to-profound, nonsyndromic sensorineural hearing loss with no consistent vestibular, syndromic, or extra-auditory features. As of 2023, only about five pathogenic EPS8* variants/families had been reported worldwide (Algerian, Chinese, Iranian), underscoring its rarity.

The mechanism is well delineated at the molecular and cellular level thanks to concordant human genetics and mouse models. EPS8 localizes to the tips of cochlear hair-cell stereocilia, where its C-terminal effector domain caps actin filament barbed ends and bundles the actin core. This activity is required for stereocilia to elongate to their correct staircase heights and for inner hair cells (IHCs) to mature into functional mechanoelectrical transducers. When EPS8 is truncated or deleted, this domain is lost; stereocilia remain abnormally short, IHCs fail to mature, mechano-electrical transduction is abolished, and profound deafness results. The Eps8-knockout mouse faithfully recapitulates the human phenotype — it is profoundly deaf with short stereocilia — and the paralog Eps8L2 divides labor with EPS8, handling stereocilia maintenance while EPS8 handles initial elongation.

Because EPS8 is broadly expressed and multifunctional (EGFR signaling, Rac regulation via the EPS8–ABI1–SOS1 complex, intestinal microvillus formation), one might expect a syndromic phenotype; however, human EPS8-null individuals present with isolated deafness only, indicating functional redundancy of EPS8 outside the cochlea (the paralogs EPS8L1/L2/L3 compensate) but a non-redundant role at stereocilia tips. Notably, the Eps8-knockout mouse displays intestinal microvillus shortening and a favorable calorie-restriction-like metabolic phenotype that is absent from human patients, an instructive species divergence. There is no disease-specific pharmacologic or gene therapy; diagnosis relies on exome/genome sequencing with copy-number analysis, and management is cochlear implantation, the standard of care for congenital severe-to-profound sensorineural hearing loss.


1. Disease Information

Overview. DFNB102 is a form of autosomal recessive nonsyndromic sensorineural hearing loss (SNHL). "Nonsyndromic" means hearing loss occurs in isolation, without associated malformations or dysfunction of other organ systems. "DFNB" designates a recessive (B) locus for deafness (DFN); "102" is its sequential locus number.

Key identifiers.

Resource Identifier
MONDO MONDO:0014428
OMIM (phenotype) 615974 (DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102)
Gene EPS8, OMIM 600206, HGNC:3555, NCBI Gene 2059, Ensembl ENSG00000151491, UniProt Q12929
Cytoband 12p12.3
ICD-10 H90.3 (sensorineural hearing loss, bilateral) — non-specific
ICD-11 AB52.0 / bilateral sensorineural hearing impairment stem — non-specific
MeSH Closest: "Hearing Loss, Sensorineural" (D006319); no DFNB102-specific MeSH term

Synonyms / alternative names. DFNB102; Deafness, autosomal recessive 102; EPS8-related nonsyndromic hearing loss; autosomal recessive nonsyndromic sensorineural deafness type DFNB102.

Information source. This entry is derived from aggregated disease-level resources (OMIM, ontology databases) and individual published case reports/families (Algerian, Chinese, Iranian), not from a large EHR cohort. The literature base is small (a handful of families).


2. Etiology

Primary cause — genetic. DFNB102 is a monogenic disorder caused by biallelic (homozygous or compound heterozygous) loss-of-function variants in EPS8. It is not caused by environmental, infectious, or acquired factors. The founding evidence: Behlouli et al. 2014 identified a homozygous nonsense variant c.88C>T (p.Gln30*) in two siblings from a consanguineous Algerian family with isolated profound congenital deafness; the variant segregated recessively (heterozygous in unaffected parents and one sib, absent from two unaffected sibs) and was absent from 120 Algerian controls and the Exome Variant Server (PMID: 24741995).

"A biallelic nonsense mutation, c.88C > T (p.Gln30), was identified in EPS8 that encodes epidermal growth factor receptor pathway substrate 8, a 822 amino-acid protein involved in actin dynamics."* — PMID: 24741995

Genetic risk factors. The causal factor is possession of two loss-of-function EPS8 alleles. Consanguinity is a major risk-elevating context (the index family was consanguineous, and homozygous LoF alleles are far more likely in consanguineous unions). Carriers (heterozygotes) are unaffected.

Environmental / lifestyle risk factors. None established for the primary (genetic) disease. General SNHL aggravators (noise, ototoxic drugs, aging) are not documented as modifiers of DFNB102 specifically.

Protective factors. No genetic or environmental protective factors are described. In principle, the paralogs EPS8L1/EPS8L2/EPS8L3 provide functional redundancy in non-cochlear tissues, explaining why the phenotype is confined to hearing (see §4, §6).

Gene–environment interactions. None documented. DFNB102 is a fully penetrant monogenic condition; environmental modulation has not been reported.


3. Phenotypes

The DFNB102 phenotype is dominated by a single, highly consistent manifestation.

Phenotype Type Onset Severity Progression Frequency Suggested HPO
Sensorineural hearing loss Clinical sign / audiometric Congenital / prelingual Severe-to-profound Non-progressive (congenitally profound) ~100% of affected HP:0000407 (SNHL); HP:0008527 (Congenital SNHL); HP:0000365 (Hearing impairment)
Bilateral involvement Clinical sign Congenital — Stable ~100% HP:0008619 (Bilateral SNHL)
Profound degree Audiometric Congenital Profound (>90 dB HL) Stable Majority HP:0011476 (Bilateral profound SNHL); HP:0000364
Absence of syndromic features — — — — — (Nonsyndromic)

Characteristics. Onset is congenital/prelingual (present at or before language acquisition). Severity is severe-to-profound; the Chinese case was congenital profound, the Algerian siblings profound. The loss is bilateral and symmetric. Because it is congenitally profound, it is best described as stable/non-progressive in patients (contrast with EPS8L2 disease, which is late-onset progressive — see §4/§15). No consistent vestibular dysfunction or balance phenotype has been reported, and no extra-auditory (syndromic) features are documented.

"an 11-month-old male infant presented with congenital profound non-syndromic hearing loss" — PMID: 34637946

Quality-of-life impact. Congenital profound hearing loss, if unaddressed in the critical period, severely impairs spoken-language acquisition, literacy, educational attainment, and social participation. Early cochlear implantation substantially mitigates these outcomes (see §11–12). Formal EQ-5D/SF-36 data specific to DFNB102 are not available given the tiny cohort.


4. Genetic / Molecular Information

Causal gene. EPS8 (Epidermal Growth Factor Receptor Pathway Substrate 8), 12p12.3; HGNC:3555; OMIM 600206; UniProt Q12929; protein length 822 aa. EPS8 is an F-actin capping and bundling protein.

"EPS8 is an F-actin capping and bundling protein." — PMID: 24741995

Reported pathogenic variants. As of 2023, only ~5 pathogenic EPS8 variants had been described (PMID: 36635257).

Variant (cDNA / protein) Type Zygosity / family Population Reference
c.88C>T (p.Gln30*) Nonsense (LoF) Homozygous, consanguineous Algerian PMID: 24741995
c.1435-2A>T (p.His479Cysfs*14) Splice-site (LoF) Compound het with CNV Chinese PMID: 34637946
~65.9 kb intragenic deletion Structural / CNV (LoF) Compound het (maternal) Chinese PMID: 34637946
Fifth reported pathogenic variant (per report) — Iranian PMID: 36635257

"Thus far, only four pathogenic variations in EPS8 have been described. In this study, we report the fifth pathogenic variant in the EPS8 gene in an Iranian patient with DFNB102." — PMID: 36635257

Variant classification & type. All reported disease alleles are pathogenic loss-of-function: nonsense, splice-site/frameshift, and a large intragenic deletion. No pathogenic missense variant establishing DFNB102 has been reported; the mechanism requires biallelic loss.

Allele frequency. Reported variants are absent or ultrarare in population databases (c.88C>T absent from 120 Algerian controls and the Exome Variant Server; PMID: 24741995). No common susceptibility allele exists.

Somatic vs germline. All variants are germline.

Functional consequence. Loss of function. Truncating and deletion alleles remove the C-terminal effector domain that carries capping/bundling activity (see §6). In the Chinese case, in vitro splicing and allele-specific expression assays confirmed near-total loss of functional transcript (0-fold WT; 0.25–0.27-fold mutant; P<0.05) (PMID: 34637946).

"further CNVs analysis identified a novel 65.9 kb intragenic deletion and was inherited from his mother" — PMID: 34637946

Modifier genes. The paralog EPS8L2 is functionally relevant: it complements EPS8 at stereocilia tips and its own loss causes progressive hearing loss (PMID: 23918390). EPS8L1/L2/L3 collectively provide redundancy outside the cochlea. No formal disease-severity modifier has been mapped for DFNB102.

Epigenetic / chromosomal. No epigenetic mechanism is implicated. The only "structural" lesion is the intragenic EPS8 deletion; no aneuploidy or translocation is associated.


5. Environmental Information

Environmental factors: None causal or contributory — DFNB102 is monogenic. Lifestyle factors: None established. Infectious agents: None — DFNB102 is not an infectious or acquired deafness (contrast with congenital CMV, rubella, ototoxic exposure). Not applicable.


6. Mechanism / Pathophysiology

Ordered causal chain (initiating lesion → clinical manifestation)

  1. Biallelic LoF variant in EPS8 (nonsense / splice / deletion) leads to absence of functional full-length EPS8 protein, specifically deleting the C-terminal effector domain that carries capping and bundling activity. (Demonstrated: human genetics + transcript assays, PMID: 24741995, PMID: 34637946.)
  2. Loss of EPS8 at stereocilia tips results in failure of barbed-end actin capping and actin-core bundling within hair-cell stereocilia. (Demonstrated in vitro/structurally: PMID: 15558031, PMID: 20532239.)
  3. Dysregulated stereocilia actin assembly leads to abnormally short stereocilia and a decayed staircase hair-bundle architecture. (Demonstrated in mouse: PMID: 21526224, PMID: 21236676.)
  4. Short/disorganized hair bundles result in failure of inner hair cells (IHCs) to mature into fully functional sensory receptors (OHCs comparatively spared). (Demonstrated: PMID: 21526224.)
  5. Immature IHCs with defective bundles abolish mechano-electrical transduction (inferred at the human level; demonstrated functionally in mouse IHC recordings).
  6. Loss of transduction results in profound congenital bilateral sensorineural hearing loss — the clinical phenotype. (Human: PMID: 24741995, PMID: 34637946.)

Branch (developmental vs maintenance): EPS8 drives initial elongation (step 3); its paralog EPS8L2 independently drives maintenance of stereocilia in adult cells. Loss of EPS8 → short bundles from the outset (DFNB102, congenital). Loss of EPS8L2 → normal build-up then decay → late-onset progressive loss (PMID: 23918390).

Molecular and structural detail

Actin capping vs bundling — separable activities. Disanza et al. 2004 showed EPS8 caps actin barbed ends with nanomolar affinity through its conserved C-terminal effector domain, with full-length EPS8 auto-inhibited in vitro and de-repressed by Abi1 (PMID: 15558031).

"proteins of another family, the Eps8 family, also show barbed-end capping activity, which resides in their conserved carboxy-terminal effector domain" — PMID: 15558031

Hertzog et al. 2010 resolved the structural basis: bundling is mediated by a compact four-helix bundle contacting three actin subunits along the filament, whereas capping is mediated by an amphipathic helix inserting into the hydrophobic pocket at the barbed end, blocking monomer addition; point mutations can dissociate the two activities (PMID: 20532239).

"The capping activity is mainly mediated by a amphipathic helix that binds within the hydrophobic pocket at the barbed ends of actin blocking further addition of actin monomers." — PMID: 20532239

Because DFNB102 truncating/deletion alleles remove this C-terminal effector domain, both capping and bundling are lost — the mechanistic crux linking genotype to stereocilia failure.

Tip complex context. EPS8 is a central actin-regulatory element within the stereocilia tip complex together with MyosinXVa (MYO15A) and whirlin (WHRN); Eps8-null bundles are shorter than MyoXVa- or whirlin-deficient bundles, placing EPS8 at the heart of elongation control (PMID: 21236676).

"MyoXVa, whirlin, and Eps8 are integral components of the stereocilia tip complex, where Eps8 is a central actin-regulatory element for elongation of the stereocilia actin core." — PMID: 21236676

Krey et al. 2023 showed EPS8 protein accumulation at row-1 tips peaks at the end of developmental stage III, coinciding with row-1 lengthening, and that mechanotransduction normally restricts EPS8 to the tallest row (PMID: 37011103).

Broader signaling role (redundant in cochlea). Outside hair cells, EPS8 regulates Rac-dependent actin remodeling and cell motility via the trimeric EPS8–ABI1–SOS1 complex, participates in EGFR signaling, and can undergo chaperone-mediated autophagy in cancer cells (PMID: 15558031, PMID: 20184880, PMID: 41974702). These functions are not manifest as disease in humans because paralogs compensate — hence isolated deafness.

Molecular pathways / GO terms. GO:0030041 (actin filament polymerization), GO:0051016 (barbed-end actin filament capping), GO:0051017 (actin filament bundle assembly), GO:0060088 (auditory receptor cell stereocilium organization), GO:0032420 (stereocilium), GO:0007605 (sensory perception of sound). Cell types (CL): CL:0000589 (cochlear inner hair cell), CL:0000601 (cochlear outer hair cell).

ASCII mechanistic model

 EPS8 biallelic LoF (nonsense/splice/deletion)
│  removes C-terminal effector domain
▼
 Loss of barbed-end CAPPING + actin BUNDLING at stereocilia tips
│
▼
 Failed stereocilia ELONGATION → short bundles, decayed staircase
│                                   ┌───────────────────────────┐
▼                                   │ Paralog division of labor: │
 IHCs fail functional MATURATION            │ EPS8  = elongation (DFNB102│
 (OHCs comparatively spared)                │ EPS8L2= maintenance →      │
│                                   │        progressive HL)     │
▼                                   └───────────────────────────┘
 Loss of mechano-electrical transduction (inferred in human)
▼
 PROFOUND CONGENITAL BILATERAL SENSORINEURAL HEARING LOSS

7. Anatomical Structures Affected

  • Organ level (primary): Inner ear — cochlea. UBERON:0001844 (cochlea), UBERON:0001846 (internal ear), UBERON:0002227 (organ of Corti / spiral organ).
  • Body system: Auditory / sensory nervous system. No secondary organ involvement in humans (nonsyndromic).
  • Tissue / cell level: Sensory neuroepithelium of the organ of Corti; specifically cochlear inner hair cells (CL:0000589) are functionally most affected, with outer hair cells (CL:0000601) comparatively spared in the knockout model (PMID: 21526224).
  • Subcellular level: The stereocilium (GO:0032420) and its actin filament core / stereocilia tip (GO:0032426 stereocilium tip). The defect is in the actin cytoskeleton (GO:0015629, actin cytoskeleton).
  • Localization / lateralization: Bilateral, symmetric cochlear involvement (HP:0008619).

8. Temporal Development

  • Onset: Congenital / prelingual; hearing loss is present from birth. Onset pattern is congenital-static rather than acquired.
  • Progression: In DFNB102 patients the loss is congenitally profound and therefore essentially stable/non-progressive (there is little residual hearing to lose). This contrasts with EPS8L2-related deafness, which is late-onset and progressive because EPS8L2 governs stereocilia maintenance rather than initial construction (PMID: 23918390).
  • Disease course / duration: Chronic, lifelong.
  • Remission: None spontaneously; functional hearing is restored only by intervention (cochlear implant).
  • Critical period: The developmental window for stereocilia elongation (in mouse, up to ~postnatal day 8, stage III–IV transition; PMID: 37011103) is when EPS8 acts. Clinically, the critical period for intervention is early infancy — early cochlear implantation optimizes language outcomes.

9. Inheritance and Population

  • Inheritance: Autosomal recessive; requires biallelic EPS8 LoF. Carriers unaffected.
  • Penetrance: Appears complete in reported biallelic individuals.
  • Expressivity: Consistent (uniformly severe-to-profound congenital SNHL) within the small cohort.
  • Genetic anticipation: Not applicable (not a repeat-expansion disorder).
  • Germline mosaicism: Not reported.
  • Consanguinity: A major contributing context — the founding family was consanguineous (Algerian); homozygous LoF alleles are enriched in consanguineous populations.
  • Founder effects: None established; the reported variants are private to individual families across different populations.
  • Carrier frequency: Unknown / presumed extremely low given ultrararity.

Epidemiology. DFNB102 is ultrarare: only ~5 pathogenic variants/families reported worldwide as of 2023 (PMID: 36635257, PMID: 34637946). For context, nonsyndromic hearing loss overall affects ~1 in 1000 newborns and is hereditary in 60–70% of cases, with GJB2 the most common cause (PMID: 19939467; PMID: 10376574); EPS8/DFNB102 accounts for a vanishingly small fraction.

"Nonsyndromic hearing loss is one of the most abundant human sensory disorders, and can be found in 1 out of 1000 newborns. In 60-70% of the cases this disorder is hereditary." — PMID: 19939467

  • Affected populations: Reported in Algerian, Chinese, and Iranian families — no single ethnic predilection beyond enrichment in consanguineous unions.
  • Geographic distribution: No endemic focus; sporadic across populations.
  • Sex ratio: No sex bias expected (autosomal); reported cases include males; sample too small for a meaningful ratio.
  • Age distribution: Congenital onset; affects all ages once present.

10. Diagnostics

Recommended approach. Diagnosis is molecular, integrated with audiometric confirmation.

  • Audiometry / physiologic testing: Newborn hearing screening (OAE/ABR), diagnostic ABR and behavioral audiometry confirm bilateral severe-to-profound SNHL.
  • Genetic testing (primary):
  • Whole-exome sequencing (WES) identified the founding variant and is the workhorse for gene discovery/diagnosis in nonsyndromic HL (PMID: 24741995).
  • Whole-genome sequencing (WGS) and, critically, copy-number/CNV analysis are needed because intragenic deletions can masquerade as homozygosity — the Chinese case required CNV detection of a 65.9 kb deletion to resolve the genotype (PMID: 34637946).
  • Hearing-loss gene panels including EPS8 are appropriate first-tier tests.
  • Functional confirmation (in vitro splicing assays, allele-specific expression) can validate splice/structural variants (PMID: 34637946).
  • Imaging: Temporal-bone CT/MRI is used to exclude inner-ear malformations and assess candidacy for cochlear implantation; no DFNB102-specific radiologic signature.
  • Biopsy/pathology: Not applicable (cochlea is not biopsied clinically).

Clinical criteria / differential diagnosis. DFNB102 is diagnosed by the combination of nonsyndromic congenital profound SNHL and biallelic EPS8 LoF. Differentials include the far more common GJB2/GJB6 deafness (PMID: 10376574), SLC26A4 (Pendred/EVA), MYO15A, TMC1, OTOF (auditory neuropathy), and syndromic causes (Usher, Pendred, Waardenburg) — distinguished by absence of syndromic features and gene-specific findings. EPS8L2 should be considered in progressive postlingual loss.

Screening. Newborn hearing screening detects the phenotype; cascade/carrier testing of relatives is appropriate once the familial variants are known. There is no population carrier-screening program specific to EPS8.


11. Outcome / Prognosis

  • Survival / mortality: DFNB102 is not life-threatening; life expectancy is normal. No disease-specific mortality.
  • Morbidity / function: The principal morbidity is communication disability from congenital profound deafness — impaired spoken-language development, education, and social participation if untreated.
  • Disease course: Chronic, stable (congenitally profound). No spontaneous recovery.
  • Recovery potential: Auditory function is not restored biologically but can be substantially rehabilitated with cochlear implantation, particularly when performed early.
  • Prognostic factors: Age at implantation, duration of auditory deprivation, and consistency of device use are the key determinants of language outcome after pediatric cochlear implantation (PMID: 41895171). Because the lesion is peripheral (hair cell/stereocilia) with an intact auditory nerve, implant candidacy and expected benefit are favorable.
  • QoL measures: No DFNB102-specific PROMIS/EQ-5D data; general pediatric cochlear-implant literature applies.

12. Treatment

There is no disease-specific pharmacologic or gene therapy for DFNB102. Management is habilitative.

Modality Detail NCIT suggestion
Cochlear implantation (standard of care) For congenital bilateral severe-to-profound SNHL with limited hearing-aid benefit; effective; best outcomes with early implantation (PMID: 41895171) NCIT:C15694 (Cochlear Implant)
Hearing aids Trialed first; typically insufficient for profound loss NCIT:C99936 (Hearing Aid)
Auditory-verbal / speech-language therapy Rehabilitation to develop spoken language post-implant NCIT:C15195 (Rehabilitation Therapy)
Educational/communication support Sign language, assistive listening, early intervention services —

"Pediatric cochlear implantation is the standard of care for infants and young children with congenital bilateral severe-to-profound sensorineural hearing loss who receive limited benefits from optimally fitted hearing aids." — PMID: 41895171

Pharmacotherapy / pharmacogenomics: None specific. Gene therapy / RNA therapy / cell therapy: None approved or in DFNB102-specific trials; inner-ear gene therapy is an active field for other deafness genes (e.g., OTOF) but not yet for EPS8. Surgical: Cochlear implant surgery as above. Experimental: No DFNB102-specific NCT-registered trials identified.


13. Prevention

  • Primary prevention: Not preventable in an affected fetus (monogenic, congenital). At the family level, genetic counseling for consanguineous or carrier couples informs reproductive options.
  • Secondary prevention (early detection): Universal newborn hearing screening enables early diagnosis and timely intervention within the critical language-development window.
  • Tertiary prevention: Early cochlear implantation and structured auditory-verbal rehabilitation prevent the developmental complications (language/educational delay) of untreated profound deafness.
  • Genetic screening / reproductive options: Carrier testing of at-risk relatives once familial variants are identified; prenatal testing and preimplantation genetic testing (PGT-M) are options for known-carrier couples.
  • Counseling: Autosomal recessive recurrence risk is 25% per pregnancy for two carrier parents — a core counseling message.
  • Immunization / public health / environmental: Not applicable (non-infectious, non-environmental).

14. Other Species / Natural Disease

  • Taxonomy / orthologs: EPS8 is conserved across vertebrates. Mouse Eps8 (NCBI Gene 13860; taxon Mus musculus, NCBI:txid10090) is the principal ortholog studied. Paralogs Eps8l1/l2/l3 exist in mouse and human.
  • Natural disease in animals: No well-characterized naturally occurring EPS8 deafness is documented in companion animals or wildlife (OMIA). The animal evidence comes from engineered models, not spontaneous disease.
  • Comparative biology: EPS8's actin capping/bundling role is conserved and pleiotropic across species — e.g., it contributes to intestinal microvillus morphogenesis in mouse (PMID: 20209148) and to actin-based structures in invertebrates such as Eriocheir sinensis spermatogenesis (PMID: 36709695). Species divergence is important: mouse Eps8 knockouts show intestinal/metabolic phenotypes that human EPS8-null patients do not (see below).
  • Zoonotic potential: None (genetic disease).

15. Model Organisms

The mouse is the definitive model and faithfully recapitulates the human cochlear phenotype, while also revealing species-specific pleiotropy.

Model Type Key phenotype Human relevance Reference
Eps8-knockout mouse Constitutive KO (mammalian) Profoundly deaf; abnormally short stereocilia; IHCs (not OHCs) fail to mature Faithful DFNB102 model PMID: 21526224, PMID: 24741995
Eps8L2-knockout mouse Constitutive KO Late-onset progressive hearing loss; gradual hair-bundle deterioration Models maintenance role / progressive HL branch PMID: 23918390
Eps8/Eps8L2 double-null Combined KO Decay of ordered staircase hair-bundle structure Demonstrates complementary roles PMID: 23918390
Eps8-KO (systemic phenotypes) Constitutive KO ~25% shorter intestinal microvilli; reduced fat absorption; resistance to diet-induced obesity; improved metabolism; increased lifespan Not seen in human patients — species divergence PMID: 20209148

"whereas Eps8 is essential for the initial elongation of stereocilia, Eps8L2 is required for their maintenance in adult hair cells. In the absence of both proteins, the ordered staircase structure of the hair bundle in the cochlea decays." — PMID: 23918390

"Eps8 knockout mice are profoundly deaf and that IHCs, but not OHCs, fail to mature into fully functional sensory receptors" — PMID: 21526224

Phenotype recapitulation. Excellent for the auditory phenotype — the Eps8-KO mouse independently established EPS8 as an essential stereocilia elongation factor before the human gene was implicated, providing strong cross-species validation.

Model limitations. The mouse KO exhibits extra-cochlear phenotypes (intestinal microvillus shortening, favorable metabolic status, longevity) absent from human isolated deafness — likely reflecting differences in paralog compensation between species. This makes the mouse imperfect for modeling the isolated human presentation but valuable for dissecting EPS8's broader actin biology.

"knockout mice for Eps8, a regulator of actin dynamics, display reduced body weight, partial resistance to age- or diet-induced obesity, and overall improved metabolic status" — PMID: 20209148

Resources: MGI (mouse Eps8), IMPC; in vitro biochemistry and structural biology of EPS8 capping/bundling (PMID: 15558031, PMID: 20532239).


Key Findings (with statistical evidence)

F1 — DFNB102 is caused by biallelic loss-of-function EPS8 variants (12p12.3). WES of a consanguineous Algerian family found homozygous c.88C>T (p.Gln30*) segregating recessively, absent from 120 controls and the Exome Variant Server (PMID: 24741995); only ~5 pathogenic variants known by 2023 (PMID: 36635257).

F2 — EPS8 controls stereocilia elongation and IHC maturation. Eps8-KO mice are profoundly deaf with short stereocilia; IHCs (not OHCs) fail to mature (PMID: 21526224); EPS8 sits in the MYO15A–whirlin tip complex as the central elongation regulator (PMID: 21236676).

F3 — Consistent clinical phenotype: prelingual, bilateral, symmetric, severe-to-profound nonsyndromic SNHL across Algerian, Chinese (compound splice + 65.9 kb deletion; transcript loss P<0.05), and Iranian cases (PMID: 34637946, PMID: 36635257).

F4 — Faithful mouse models; EPS8 vs EPS8L2 divide developmental vs maintenance roles (PMID: 23918390, PMID: 37011103).

F5 — EPS8 is a multifunctional EGFR-pathway actin regulator with a non-redundant cochlear role — broad expression yet isolated deafness implies paralog redundancy elsewhere (PMID: 24741995, PMID: 41974702).

F6 — Ultrarare; diagnosed by WES/WGS + CNV analysis; managed by cochlear implantation (PMID: 19939467, PMID: 41895171).

F7 — Mouse-specific intestinal/metabolic phenotype absent in humans (~25% shorter microvilli, improved metabolism; PMID: 20209148).

F8 — Separable capping and bundling encoded by the C-terminal effector domain, both required and both lost by truncating alleles (PMID: 15558031, PMID: 20532239).


Evidence Base

PMID How it supports the findings
24741995 Founding paper: EPS8 = DFNB102 gene; c.88C>T; defines EPS8 as F-actin capping/bundling protein
34637946 Compound splice variant + 65.9 kb intragenic deletion; congenital profound nonsyndromic HL; CNV diagnostics
36635257 Fifth pathogenic variant (Iranian); confirms rarity
21526224 Eps8-KO mouse: profound deafness, short stereocilia, IHC maturation failure
21236676 EPS8 central in MYO15A–whirlin tip complex for actin-core elongation
23918390 EPS8L2 maintenance role; double-null staircase decay; progressive HL branch
37011103 EPS8 timing at stereocilia tips; transduction restricts EPS8 to tallest row
15558031 Barbed-end capping resides in C-terminal effector domain; Abi1 de-repression; Rac via EPS8–Abi1–Sos1
20532239 Structural basis: helix-bundle bundling vs amphipathic-helix capping; separable activities
20209148 Mouse intestinal/metabolic phenotype (species divergence)
41974702 EPS8–ABI1 complexes in non-cochlear actin remodeling
41895171 Cochlear implantation as standard of care
19939467, 10376574 Epidemiologic context for nonsyndromic HL and GJB2 differential

Evidence-type mix: Human clinical genetics (24741995, 34637946, 36635257); model organism (21526224, 21236676, 23918390, 37011103, 20209148); in vitro/structural biochemistry (15558031, 20532239); clinical management (41895171).


Limitations and Knowledge Gaps

  1. Tiny cohort. Fewer than ~5 families worldwide. Estimates of penetrance, expressivity, sex ratio, and full phenotypic range (e.g., subtle vestibular involvement) are consequently uncertain.
  2. No human histopathology. The stereocilia/IHC mechanism is proven in mouse; the human cellular lesion is inferred, not directly demonstrated.
  3. No missense-variant genotype–phenotype data. All reported alleles are truncating/deletion; whether hypomorphic missense alleles could cause milder or progressive loss is unknown.
  4. Species divergence. Mouse KO extra-cochlear phenotypes (intestinal, metabolic, longevity) complicate translation and are unexplained in terms of human paralog compensation.
  5. No natural animal disease and no DFNB102-specific therapeutics (no gene/RNA therapy trials).
  6. No population carrier-frequency data for EPS8 LoF alleles.
  7. Non-specific ICD/MeSH coding limits registry-based epidemiology.

Proposed Follow-up Experiments / Actions

  1. International case aggregation (e.g., GeneMatcher, deafness gene registries) to expand the DFNB102 cohort, refine phenotype (including vestibular testing), and estimate penetrance/expressivity.
  2. gnomAD LoF audit of EPS8 to estimate carrier frequency and predicted disease incidence, and to check for any biallelic LoF individuals without reported deafness (redundancy test).
  3. Functional classification pipeline for candidate EPS8 missense/splice VUS (minigene splicing assays, allele-specific expression) to enable confident clinical reporting — extending the approach validated in PMID: 34637946.
  4. Human iPSC-derived inner-ear organoids carrying DFNB102 alleles to directly test stereocilia elongation and transduction in a human cellular context, closing the human-histopathology gap.
  5. Structure-guided rescue experiments using capping-only vs bundling-only EPS8 constructs (PMID: 20532239) in Eps8-null hair cells to determine which activity is limiting for stereocilia elongation — informing future gene-therapy payload design.
  6. Cochlear-targeted gene-replacement proof-of-concept (AAV-EPS8) in the Eps8-KO mouse during the neonatal critical window (PMID: 37011103) to test biological rescue.
  7. Cochlear-implant outcome tracking specifically in genetically confirmed DFNB102 patients, contributing to etiology-driven implant management (PMID: 41895171).

Report compiled from 8 confirmed findings and 27 reviewed papers across a 5-iteration autonomous investigation. Evidence sources are labeled by type (human clinical, model organism, in vitro/structural, clinical management). Ontology suggestions: MONDO:0014428; HGNC:3555 (EPS8); UBERON:0001844 (cochlea), UBERON:0002227 (organ of Corti); CL:0000589 (cochlear inner hair cell), CL:0000601 (cochlear outer hair cell); GO:0051016 (barbed-end actin filament capping), GO:0051017 (actin filament bundle assembly), GO:0060088 (auditory receptor cell stereocilium organization), GO:0032420 (stereocilium); NCIT:C15694 (Cochlear Implant).

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome Count
References checked 16
Resolved 16
Unresolved (possible confabulation) 0
Unverifiable 0
References weighed for topical relevance 16
On topic 8
Off topic 0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome Count
Terms checked 24
Resolved 23
Unresolved (possible confabulation) 0
Obsolete 0
Unverifiable 1
Terms whose name was checked 16
Terms named correctly 9
Terms named as a different term 4
Terms whose name is worth a second look 3

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

  • MONDO:0014428 (3 mentions) - the report calls it "MONDO"; MONDO calls it autosomal recessive nonsyndromic hearing loss 102
  • HP:0008619 (2 mentions) - the report calls it "Bilateral SNHL", "Localization / lateralization: Bilateral, symmetric cochlear involvement"; HP calls it Bilateral sensorineural hearing impairment**
  • NCIT:C15694 (2 mentions) - the report calls it "Cochlear Implant"; NCIT calls it Phase II/III Trial
  • NCIT:C99936 (1 mention) - the report calls it "Hearing Aid"; NCIT calls it Catecholaminergic Polymorphic Ventricular Tachycardia by ECG Finding

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

  • GO:0032420 (3 mentions) - the report calls it "stereocilium", "Subcellular level: The stereocilium"; GO calls it stereocilium
  • UBERON:0002227 (2 mentions) - the report calls it "organ of Corti / spiral organ", "organ of Corti"; UBERON calls it spiral organ of cochlea, and lists "spiral organ of Corti" among its other names
  • NCIT:C15195 (1 mention) - the report calls it "Rehabilitation Therapy"; NCIT calls it Brachytherapy, and lists "Radiation Brachytherapy" among its other names

Terms named inconsistently

The report gives these identifiers more than one name of its own:

  • HP:0008619 - called "Bilateral SNHL", "Localization / lateralization: Bilateral**, symmetric cochlear involvement"
  • GO:0032420 - called "stereocilium", "Subcellular level: The stereocilium"
  • CL:0000589 - called "cochlear inner hair cell", "cochlear inner hair cells"
  • UBERON:0002227 - called "organ of Corti / spiral organ", "organ of Corti"